Is locking plate fixation a better option than casting for distal radius fracture in elderly people?

Hong Kong Med J 2015 Oct;21(5):407–10 | Epub 3 Jul 2015
DOI: 10.12809/hkmj144440
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Is locking plate fixation a better option than casting for distal radius fracture in elderly people?
LP Hung, MRCSEd1; YF Leung, FHKAM (Orthopaedic Surgery)1; WY Ip, MS, FHKAM (Orthopaedic Surgery)2; YL Lee, FHKAM (Orthopaedic Surgery)1
1 Department of Orthopaedics and Traumatology, Tseung Kwan O Hospital, Tseung Kwan O, Hong Kong
2 Department of Orthopaedics and Traumatology, Queen Mary Hospital, Pokfulam, Hong Kong
Corresponding author: Dr LP Hung (joshua.hlp@gmail.com)
 
 Full paper in PDF
Abstract
Objectives: To compare the outcomes of locking plate fixation versus casting for displaced distal radius fracture with unstable fracture pattern in active Chinese elderly people.
 
Design: Historical cohort study.
 
Setting: Orthopaedic ward and clinic at Tseung Kwan O Hospital, Hong Kong.
 
Patients: Between 1 May 2010 and 31 October 2013, 57 Chinese elderly people aged 61 to 80 years were treated either operatively with locking plate fixation (n=26) or conservatively with cast immobilisation (n=31) for unstable displaced distal radius fracture.
 
Main outcome measures: Clinical, radiological, and functional outcomes were assessed at 9 to 12 months after treatment.
 
Results: The functional outcome (based on the quick Disabilities of the Arm, Shoulder and Hand score) was significantly better in the locking plate fixation group than in the cast immobilisation group, while clinical and radiological outcomes were comparable with those in other similar studies.
 
Conclusions: Locking plate fixation resulted in better functional outcome for displaced distal radius fracture with unstable fracture pattern in active Chinese elderly people aged 61 to 80 years. Further prospective study with long-term follow-up is recommended.
 
 
New knowledge added by this study
  • In active Chinese elderly people aged 61 to 80 years, apart from better clinical and radiological outcomes than cast immobilisation, locking plate fixation for displaced distal radius fracture with unstable fracture pattern also improves functional outcome.
Implications for clinical practice or policy
  • We advise management of displaced distal radius fracture with unstable fracture pattern with locking plate fixation in active Chinese elderly people aged 61 to 80 years.
 
 
Introduction
Since the introduction of locking plate fixation, there has been a tendency to manage distal radius fracture in elderly people with plate fixation over cast fixation. In the US, the rate of plate fixation in elderly people increased 5-fold from 3% in 1996 to 16% by 2005.1
 
Only a few recent studies have compared conservative versus operative management of distal radius fracture in elderly people. Some authors have concluded that, while grip strength was significantly better after operation, functional outcome did not improve.2 3
 
In Hong Kong, Chinese elderly people tend to have poorer bone quality than western people of the same age.4 Life expectancies in Hong Kong, however, are one of the longest in the world, at 80.9 years for men and 86.6 years for women in 2013.5 Moreover, an increasing number of people older than 60 years are still working and therefore the expectation for clinical outcomes after distal radius fracture will be higher than that in the past. As a result, it is imperative to investigate whether locking plate fixation is a good option in treating distal radius fracture in Chinese elderly people. The aim of this study was to compare the outcomes between locking plate fixation and cast immobilisation as treatment for displaced distal radius fracture with unstable fracture pattern in Chinese elderly people.
 
Methods
The hospital database was reviewed for elderly patients with distal radius fracture from 1 May 2010 to 31 October 2013. The study was approved by the Research Ethics Committee of the Hospital Authority, Hong Kong.
 
The operation rate for distal radius fracture decreased with age and elderly patients (>70 years) tended to prefer conservative management. The oldest patient who underwent locking plate fixation was 77 years. As a result, our inclusion criteria were: Chinese patients, aged 61 to 80 years, having displaced distal radius fracture with unstable fracture pattern (defined as having at least three out of five criteria of: initial dorsal angulation >20°, initial shortening >5 mm, >50% dorsal comminution, intra-articular fracture, and ulnar fracture6), and completion of a rehabilitation programme after either operative or conservative management.
 
The exclusion criteria were: operative management other than 2.4- or 3.5-mm locking compression plates (eg K-wire fixation, non-locking plate fixation, or external fixation), open fracture or neurovascular deficits requiring immediate operative management, concomitant same-side upper limb injury (eg elbow dislocation, shoulder dislocation, or humeral fracture) that affected the overall functional outcome, and a history of medical illness (eg stroke or dementia) that hindered the rehabilitation results.
 
A total of 57 patients were identified. All of the patients were active, independent in activities of daily living, and otherwise healthy. The patients were admitted to orthopaedic ward at Tseung Kwan O Hospital, Hong Kong from the Accident and Emergency Department. Initial closed reduction of distal radius fracture under local anaesthesia and immobilisation with a backslab were performed. Options of conservative management with cast immobilisation or operative management with locking plate fixation and the associated risks and complications were discussed with the patients. The patient made the final decision with written consent for either treatment.
 
For patients who opted for cast immobilisation, the reduced fracture was immobilised with a short arm cast for 6 weeks, followed by mobilisation and strengthening exercises. For patients who opted for locking plate fixation, the operation was done under general anaesthesia with an arm tourniquet. The modified Henry approach was used and the fracture was fixed with a 2.4- or 3.5-mm locking compression plate, followed by immediate mobilisation and then strengthening exercises. All patients were reviewed regularly in the orthopaedic out-patient clinic, with serial radiographs and rehabilitation until they reached the maximal improvement in range of motion and grip strength.
 
At the beginning of this retrospective study, the majority of the patients had been discharged from the clinic. In view of the technical difficulty of calling back elderly patients for physical assessment, the clinical parameters recorded in the last section of the rehabilitation programme were collected and the last radiographs taken in the clinic were retrieved for measurement. The duration from treatment to the last section of the rehabilitation programme averaged 10 months (range, 6-12 months) and the duration from treatment to the last radiographs averaged 9 months (range, 6-14 months).
 
Clinical parameters, including range of motion and grip strength of both hands, were measured by physiotherapists and occupational therapists not involved in this study. Radiographic parameters—including volar tilt, radial inclination, radial length, and ulnar variance—were measured by one of the investigators.
 
Functional outcome was assessed using the quick Disabilities of the Arm, Shoulder and Hand questionnaire (DASH) score at a mean of 12 months (range, 6-24 months) after treatment; DASH score is a measure of a patient’s perceived disability. The quick DASH was chosen instead of the full DASH because the elderly patients generally had a low educational background, making completion of a comprehensive questionnaire difficult. The 11-question evaluation was completed by means of an interview in the clinic, a telephone interview, or answers to a mailed questionnaire. In summary, clinical, radiological, and functional outcomes were assessed at 9 to 12 months after treatment.
 
Data were assessed with different statistical tests. For categorical variables, Chi squared test (for sex and side of injury) and analysis of variance (for Orthopaedic Trauma Association classification) were used. For continuous variables, independent sample t test was used for normally distributed data (including grip strength and radiographic parameters) and Mann-Whitney U test for non-normally distributed data (including age, range of motion, and quick DASH score). A P value of ≤0.05 was considered statistically significant.
 
Results
Of 57 patients enrolled in this study, 26 were treated with locking plate fixation and 31 were treated with cast immobilisation. The number of patients in the cast immobilisation group was low because many of them were either excluded due to stable fracture pattern (n=31) or were lost to follow-up in the rehabilitation programme (n=49). There were no statistically significant differences in characteristics between the two groups (Table 1).
 

Table 1. Patient characteristics
 
Clinical outcomes are shown in Table 2. Grip strength was presented in the form of fraction of grip strength in the non-injured side as the denominator. The operative group did not achieve significantly better range of motion when compared with the cast immobilisation group, but grip strength was significantly better. Only one complication was documented, which was carpal tunnel syndrome after cast immobilisation. There was a statistically significant improvement in the radiographic parameters (except for radial length) after anatomical reduction in the operative group (Table 3). Regarding functional outcome, the operative group perceived significantly less disability than the cast immobilisation group (Table 4).
 

Table 2. Clinical outcomes
 

Table 3. Radiographic variables
 

Table 4. Functional outcome
 
Discussion
This study found that locking plate fixation for displaced, unstable distal radius fracture achieved significantly better grip strength, radiographic parameters, and functional outcome when compared with cast immobilisation in elderly people aged 61 to 80 years.
 
Whether anatomical reduction results in better functional outcome in elderly people with displaced distal radius fracture of unstable fracture pattern is still a controversial topic. Some authors have reported satisfactory functional outcome after cast immobilisation for displaced distal radius fracture in low-demand elderly people, regardless of the radiographic result.7 8 In the younger age-group, reconstruction of articular congruity of displaced intra-articular distal radius fractures by means of internal fixation and/or external fixation have long been known to improve functional outcome.9 Only a few studies in the literature have investigated this correlation in elderly patients.
 
One historical cohort study compared the outcomes of 90 patients older than 65 years who were treated either operatively with plate-and-screw fixation or external fixation, or conservatively with cast immobilisation.3 Grip strength and radiographic parameters were superior in the operative group, but there was no difference in other outcomes including DASH score.3 In one prospective randomised trial, 73 patients aged 65 years or older were randomised to receive open reduction internal fixation with volar locking plate or closed reduction and cast immobilisation.2 Similar results were reported. Lastly, in one diagnostic study examining 53 patients older than 55 years, operative intervention was found to have no influence on functional outcome.10
 
Our study has a discrepancy for functional outcome, although clinical and radiological outcomes were consistent with the previous studies. Our opinion is that the previous studies included some patients older than 80 years, for whom operation might not be suitable due to poorer premorbid status and lower functional demand than those aged 61 to 80 years. Therefore, the overall functional outcome did not improve after operation. We believe that locking plate fixation for active Chinese elderly people aged up to 80 years could achieve good clinical, radiological, and functional outcomes. However, the decision should not only be determined by chronological age but also be balanced with functional age and medical condition.
 
There are some limitations to this study. Since it is a non-randomised study, there might have been bias during discussion of the treatment options with the patients. Moreover, the two groups of patients were not blinded (and could not be blinded) to the therapists and investigator in assessing the clinical and radiological outcomes, which might have resulted in information bias. A substantial number of eligible patients defaulted the rehabilitation programme (four in the operative group, 49 in the cast immobilisation group) and were counted as loss to follow-up. Therefore, there was a possibility of self-selection bias among the remaining patients, who had better motivation for rehabilitation and regaining functions. Other confounding factors, such as differences in background characteristics and expectations of outcome, might have made the two groups of patients non-comparable. The follow-up duration was relatively short due to limitations of human resources. The times for assessing outcomes were not standardised due to the retrospective nature of this study. The sample size was relatively small due to the strict inclusion and exclusion criteria, especially after exclusion of patients older than 80 years, but this resulted in significantly better functional outcome. Lastly, the quick DASH score might have been affected by previous injury or degenerative arthritis of the same upper limb. Using a wrist-specific score such as the Mayo wrist score or Patient-Rated Wrist Evaluation, however, could not reflect how the whole upper limb compensates for the wrist function in elderly patients after distal radius fracture.
 
Conclusions
We advise operation with locking plate fixation for displaced distal radius fracture with unstable fracture pattern in active Chinese elderly patients aged 61 to 80 years. Nevertheless, further prospective study such as a randomised controlled trial is needed to resolve this controversy.
 
Acknowledgements
Special thanks to the many dedicated colleagues from the Physiotherapy and Occupational Therapy Departments of Tseung Kwan O Hospital.
 
References
1. Chung KC, Shauver MJ, Birkmeyer JD. Trends in the United States in the treatment of distal radial fractures in the elderly. J Bone Joint Surg Am 2009;91:1868-73. Crossref
2. Arora R, Lutz M, Deml C, Krappinger D, Haug L, Gabl M. A prospective randomized trial comparing nonoperative treatment with volar locking plate fixation for displaced and unstable distal radial fractures in patients sixty-five years of age and older. J Bone Joint Surg Am 2011;93:2146-53. Crossref
3. Egol KA, Walsh M, Romo-Cardoso S, Dorsky S, Paksima N. Distal radial fractures in the elderly: operative compared with nonoperative treatment. J Bone Joint Surg Am 2010;92:1851-7. Crossref
4. Lau EM, Lynn H, Woo J, Melton LJ 3rd. Areal and volumetric bone density in Hong Kong Chinese: a comparison with Caucasians living in the United States. Osteoporos Int 2003;14:583-8. Crossref
5. Stoker S, editor. Hong Kong 2013. Information Services Department, Hong Kong Special Administrative Region Government; 2013.
6. Lafontaine M, Hardy D, Delince P. Stability assessment of distal radius fractures. Injury 1989;20:208-10. Crossref
7. Anzarut A, Johnson JA, Rowe BH, Lambert RG, Blitz S, Majumdar SR. Radiologic and patient-reported functional outcomes in an elderly cohort with conservatively treated distal radius fractures. J Hand Surg Am 2004;29:1121-7. Crossref
8. Young BT, Rayan GM. Outcome following nonoperative treatment of displaced distal radius fractures in low-demand patients older than 60 years. J Hand Surg Am 2000;25:19-28. Crossref
9. Trumble TE, Schmitt SR, Vedder NB. Factors affecting functional outcome of displaced intra-articular distal radius fractures. J Hand Surg Am 1994;19:325-40. Crossref
10. Synn AJ, Makhni EC, Makhni MC, Rozental TD, Day CS. Distal radius fractures in older patients: is anatomic reduction necessary? Clin Orthop Relat Res 2009;467:1612-20. Crossref

Angiographic factors associated with haemorrhagic presentation of brain arteriovenous malformation in a Chinese paediatric population

Hong Kong Med J 2015 Oct;21(5):401–6 | Epub 31 Jul 2015
DOI: 10.12809/hkmj144339
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Angiographic factors associated with haemorrhagic presentation of brain arteriovenous malformation in a Chinese paediatric population
Elaine WS Fok, FRCR, FHKCR1; WL Poon, FRCR, FHKAM (Radiology)1; KS Tse, FRCR, FHKAM (Radiology)1; HY Lau, FRCR, FHKAM (Radiology)1; CH Chan, MB, BS, FRCR2; NY Pan#, FRCR, FHKAM (Radiology)2; HY Cho, FRCR, FHKAM (Radiology)2; TW Yeung, FRCR, FHKCR3; YC Wong, FRCR, FHKAM (Radiology)3; KW Leung, FRCR, FHKAM (Radiology)4; Jennifer LS Khoo, FRCR, FHKAM (Radiology)4; KW Tang, FRCR, FHKAM (Radiology)1
1 Department of Radiology and Imaging, Queen Elizabeth Hospital, Jordan, Hong Kong
2 Department of Radiology, Kwong Wah Hospital, Yaumatei, Hong Kong
3 Department of Radiology and Nuclear Medicine, Tuen Mun Hospital, Tuen Mun, Hong Kong
4 Department of Radiology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
# Currently at Department of Radiology, Princess Margaret Hospital, Laichikok, Hong Kong
Corresponding author: Dr Elaine WS Fok (elainefokws@gmail.com)
 
 Full paper in PDF
Abstract
Objective: To identify specific angiographic factors associated with haemorrhagic presentation of brain arteriovenous malformation in Chinese paediatric patients.
 
Design: Retrospective cross-sectional observational study.
 
Setting: Four locoregional tertiary neurosurgical centres in Hong Kong: Queen Elizabeth Hospital, Tuen Mun Hospital, Kwong Wah Hospital, and Pamela Youde Nethersole Eastern Hospital.
 
Patients: Patients aged 18 years or younger who underwent pretreatment digital subtraction angiography for brain arteriovenous malformation between 1 January 2005 and 31 July 2013 were included. Patients were divided into haemorrhagic and non-haemorrhagic groups based on the initial presentation. Pretreatment digital subtraction angiographies were independently reviewed by two experienced neuroradiologists.
 
Main outcome measures: The following parameters were evaluated for their association with haemorrhagic presentation by univariate and multivariate analyses: nidus location, nidus size, nidus morphology (diffuse or compact); origin and number of arterial feeders; venous drainage; number of draining veins; presence of aneurysms, venous varices, and venous stenosis.
 
Results: A total of 67 children and adolescents (28 male, 39 female) with a mean age of 12 years were included. Of them, 52 (78%) presented with haemorrhage. Arteriovenous malformation size (P=0.004) and morphology (P=0.05) were found to be associated with haemorrhagic presentation by univariate analysis. Small arteriovenous malformation nidus size and diffuse nidal morphology were identified as independent risk factors for haemorrhage by multivariate analysis.
 
Conclusion: Smaller arteriovenous malformation size and diffuse nidal morphology are angiographic factors independently associated with haemorrhagic presentation. Bleeding risk is important in determining the therapeutic approach (aggressive vs conservative) and timeframe, particularly in paediatric patients.
 
 
New knowledge added by this study
  • Studies on paediatric arteriovenous malformation (AVM) are scarce and mostly based in Caucasian populations. This multicentre study involving Chinese paediatric patients found that small AVM nidus size and diffuse nidal morphology are independent risk factors for haemorrhage.
Implications for clinical practice or policy
  • These two angiographic features associated with haemorrhagic presentation can help local clinicians to assess bleeding risk and determine the therapeutic approach (aggressive vs conservative) and treatment timeframe in paediatric patients with cerebral AVM.
 
 
Introduction
Brain arteriovenous malformation (AVM) is a vascular abnormality that consists of multiple fistulous connections between arteries and veins without a normal intervening capillary bed. It is believed to be congenital in nature, and commonly presents in early adulthood.1 The usual clinical presentations of brain AVM include haemorrhage, seizures, headache, and progressive neurological deficit. About 52% to 77% of patients with AVM have initial haemorrhagic presentation,2 3 4 which is also associated with poorer prognosis. Various studies evaluating the history of AVM record an annual haemorrhage rate of about 2% to 4%.1 5
 
Computed tomography (CT) is the initial screening tool for identifying haemorrhage and demonstrating the location of the AVM. Subsequent angiographic evaluation is required for virtually all patients with suspected AVM, with digital subtraction angiography (DSA) being accepted as the gold standard for characterisation and grading. The information obtained from the angiogram is crucial in treatment decision-making and prognostication.
 
Brain AVM is an important cause of haemorrhagic stroke in children.6 7 8 Studies in adults have identified radiological features that are associated with haemorrhagic presentation and future haemorrhage.9 10 11 Similar studies on AVM in children are, however, scarce and mostly based on studies from Europe and North America.12 13 Whether those angiographic features that predict haemorrhage in Caucasian children with AVM similarly predict haemorrhage in Chinese children with AVM is unknown.
 
The objective of this multicentre study was to determine specific angiographic factors associated with haemorrhagic presentation in brain AVM in the Hong Kong Chinese paediatric population, with a view to assisting clinical decision-making regarding the optimal timing and type of treatment.
 
Methods
This was a multicentre retrospective cross-sectional observational study. We included patients aged 18 years or younger (at time of diagnosis) who underwent pretreatment cerebral DSA for a principal diagnosis of brain AVM from 1 January 2005 to 31 July 2013.
 
Patients were recruited from four locoregional tertiary neurosurgical centres in Hong Kong: Queen Elizabeth Hospital, Tuen Mun Hospital, Kwong Wah Hospital, and Pamela Youde Nethersole Eastern Hospital. These are the major acute hospitals belonging to the catchment areas of Kowloon Central, New Territories West, Kowloon West, and Hong Kong East clusters, respectively, according to the geographical cluster designation by the Hospital Authority. These clusters serve approximately 4 million Hong Kong inhabitants. Consecutive patients were retrieved from the Clinical Data Analysis and Reporting System by entering the targeted date range (01 January 2005 to 31 July 2013, inclusive) and the following search parameters: age range (0-18 years); International Classification of Diseases, 9th Revision, diagnostic code (747.81, AVM); and procedure code (88.41, arteriography of cerebral arteries). Exclusion criteria included a lack of accessible pretreatment DSA, other angiographic diagnoses (eg spinal AVM, vein of Galen aneurysmal malformation, dural arteriovenous fistulae), and non-Chinese ethnicity based on data extracted from the electronic Patient Record (ePR) and radiology reports. Approval was obtained from the institutional ethics committee and patient consent was waived for this retrospective study.
 
Basic demographic factors, including age at presentation and clinical symptoms, were obtained from the ePR. Patients were divided into a haemorrhagic group (those presenting with intracranial haemorrhage) and a non-haemorrhagic group based on the CT of the brain at presentation. Pretreatment DSAs were independently reviewed by two experienced interventional neuroradiologists (with 7 years and 15 years of experience) who were blinded to the clinical presentation and provided with the same demographic data. Each brain AVM was evaluated for the following parameters: nidus location (deep: thalamus, basal ganglia, corpus callosum, or brain stem vs hemispheric: cerebral or cerebellar lobes), nidus size (small <3 cm vs medium 3-6 cm vs large >6 cm), nidus morphology (compact: little or no intervening brain within the nidus vs diffuse: presence of significant intervening brain within the nidus) [Figs 1 and 2], origin of arterial feeders (cortical vs deep), number of arterial feeders (single vs multiple), presence of either flow-related or intranidal aneurysms (yes vs no), venous drainage destination (superficial vs deep), number of draining veins (single vs multiple), presence of venous varices (yes vs no), and presence of venous stenosis (yes vs no). Any discrepancy in reviews between the two neuroradiologists was resolved by mutual consensus.
 

Figure 1. Left occipital arteriovenous malformation, supplied solely by the posterior circulation via branches of the left posterior cerebral artery (solid arrow) and with deep venous drainage into the sigmoid sinus (dashed arrow)
The nidus (arrowhead) is compact (nodular or mass-like) and small, measuring 1.5 cm
 

Figure 2. (a) Anterior and (b) lateral views of an arteriovenous malformation in the splenium of the corpus callosum, with arterial supply from the splenial branch of the left posterior cerebral artery (solid arrows) and deep venous drainage into the great vein of Galen (dashed arrow). The nidus (arrowheads) is small (measuring <3 cm) and diffuse in morphology
 
Association between the angiographic features and haemorrhage was analysed using Chi squared test and Fisher’s exact test for categorical variables, and Student’s t test for numerical variables in univariate analysis. Logistic regression (with “enter” strategy) was carried out for covariates with a P value of <0.15. All statistical calculations were performed using the Statistical Package for the Social Sciences (Windows version 16.0; SPSS Inc, Chicago [IL], US).
 
Results
The sample included 67 children and adolescents who were eligible for inclusion, of which 28 (42%) were boys and 39 (58%) were girls. Among the patients, 52 (78%) were in the haemorrhagic group and 15 (22%) were in the non-haemorrhagic group. The mean age at presentation was 12 years (range, 2-18 years). No significant differences in age (P=0.15) or sex (P=0.88) were demonstrated between the haemorrhagic and non-haemorrhagic groups. Of the 67 patients, one in the haemorrhagic group was known to have idiopathic thrombocytopenic purpura. The remaining 66 patients had no known medical condition predisposing to intracranial haemorrhage.
 
Of the 67 children, 25 (37%) presented with headache, 12 (18%) with hemiplegia, 11 (16%) with convulsion, seven (10%) with collapse, three (4%) with loss of consciousness, one (1%) with cerebellar signs, and eight (12%) had other features, including confusion, decreased responsiveness, numbness, and restricted ocular motion. There were more asymptomatic patients in the non-haemorrhagic group (Fig 3). Three patients, all of whom were in the non-haemorrhagic group, were diagnosed incidentally with AVM during examination for precocious puberty, scalp haemangioma, and suspected neurofibromatosis type 1.
 

Figure 3. Presenting symptoms in the haemorrhagic and non-haemorrhagic groups
 
The frequency of haemorrhage of the 67 patients as a function of angioarchitectural features is shown in Table 1.
 

Table 1. Frequency of haemorrhage as a function of angioarchitectural features in paediatric brain arteriovenous malformation (n=67)
 
After univariate analysis, AVM size (P=0.004) and morphology (P=0.05) were the two factors found to be significantly associated with haemorrhagic presentation (Table 2). After multivariate analysis, small AVM size and diffuse nidal morphology were identified as independent risk factors for haemorrhage (Table 3). The odds of haemorrhagic presentation in patients with small AVM was about 9 times that of patients with medium-size AVM, whereas the odds for haemorrhagic presentation in patients with diffuse nidal morphology was approximately 12 times that of patients with compact AVM morphology. Factors found not to be statistically significantly associated with haemorrhagic presentation included location, origin of arterial feeders, number of arterial feeders, presence of related aneurysms, venous drainage, number of draining veins, presence of venous varices, and presence of venous stenosis.
 

Table 2. Univariate analysis of the angiographic features associated with haemorrhagic presentation
 

Table 3. Multivariate analysis of the angiographic features associated with haemorrhagic presentation
 
Discussion
To date, DSA remains the gold standard for evaluating brain AVM owing to its superior temporal and spatial resolution, with the ability to provide dynamic information and allow accurate identification of supplying arteries and draining veins. Generally CT and magnetic resonance angiography studies do not provide important dynamic information on the arterial supply and venous drainage.
 
Current treatment approaches for brain AVM include microsurgical resection, stereotactic radiosurgery, embolisation, a combination of these methods, and watchful waiting. As each patient with AVM is different, there is no universal algorithm or protocol to be followed. The management of brain AVM is highly individualised, requiring careful consideration of multiple factors, including lesion-related factors (eg size, location, and configuration) which can be obtained from cerebral angiogram; patient-related factors (eg life expectancy, general health, and lifestyle); and treatment-related risks. Children with AVM pose a particular problem in that they have a high cumulative bleeding risk due to their young age at presentation, and any insult to the developing brain (either spontaneous haemorrhage or treatment-related morbidity) may have lifelong and profound sequelae.14
 
To the best of our knowledge, our study is the first to evaluate the risk factors for brain AVM haemorrhage in Chinese paediatric patients. Ethnic differences exist in the incidence and haemorrhagic risk of AVM, and data from western populations are not routinely generalisable to the Chinese population. A cohort study of 1028 adult patients with AVM in the US has established a role of ethnic differences in brain AVM, with excess incidence in Asians, blacks, and Hispanics compared with Caucasians.15 The analysis reveals a statistically significant increased risk for subsequent AVM haemorrhage among Hispanics compared with Caucasians, and an insignificant trend for blacks and Asians.
 
Studies in adults have identified specific angiographic features of AVM that are associated with haemorrhagic presentation and future bleeding, including small size (<3 cm), deep location, deep venous drainage, single draining vein, intranidal aneurysms, and associated venous ectasia or stenosis.5 14 16 17
 
Our study identified small AVM size (<3 cm) to be an independent risk factor for haemorrhage. Small AVM size has been identified as a risk factor for haemorrhage in multiple adult studies,5 18 19 20 which is also demonstrated in a western paediatric population.12 Although the underlying pathophysiological mechanism is uncertain, some authors have postulated a relationship between AVM size and feeding artery pressures.8 12 Spetzler et al17 found a higher rate of haemorrhagic presentation among smaller AVMs and noted that smaller AVMs were associated with higher feeding artery pressures at the time of surgical management as well as larger haematoma sizes.
 
Diffuse AVM nidal morphology was identified as another independent risk factor for haemorrhage in our study. Although a similar relationship between morphology and haemorrhage was not demonstrated in a Caucasian paediatric population,12 diffuse AVM nidal morphology has been demonstrated in adults as a risk factor for haemorrhage.21 The underlying pathophysiological mechanism is uncertain. More information is needed to determine whether diffuse morphology is associated with haemodynamic aberrations such as increased pressure in the feeding artery or draining vein to account for the observed increased risk of haemorrhage.
 
Our study has several limitations. First, owing to the retrospective nature of this study, AVM patients with poorer clinical presentation who are unfit for DSA were not included. Second, although this is a multicentre study, the sample size was relatively small owing to the small number of paediatric patients undergoing DSA for AVM. Our study has also underestimated the haemorrhagic proportion of the study population, thus any potential associations between other angiographic features with haemorrhagic presentation that are more subtle to detect would remain undetected. Third, variations exist in the quality and amount of available angiographic images, as well as in the level of experience of the angiographers among the various centres; these may affect the radiological interpretation. Presence of intracranial haemorrhage can be inferred from the pretreatment DSA due to presence of blood vessel displacement, which is an inherent limitation of this study. Fourth, as presence of haemorrhage may render an originally compact nidus into a diffuse morphology, this is a limiting factor in determining the association between diffuse morphology and haemorrhagic presentation. Fifth, we were unable to control for the timing of DSA following the onset of presentation owing to the retrospective nature of this study. Lastly, the extent to which certain angiographic risk factors existent at the time of haemorrhagic presentation can be extrapolated as predictors of future haemorrhage in AVM is controversial. In other words, factors present at the time of presentation are not necessarily accurate predictors of future risk. For instance, several adult-based studies have identified a higher incidence of haemorrhagic presentation in small AVMs, but failed to find an association between AVM size and future haemorrhage.22 23
 
Unlike in adults, large-scale prospective studies aiming to study the natural course of paediatric AVMs are unlikely to take place owing to the relatively strong argument against conservative treatment, according to the prevailing view that ruptured paediatric AVMs should be treated aggressively owing to the significant risk of recurrent haemorrhage and subsequent morbidity and mortality.12 24 The recent controversial ARUBA (A Randomised trial of Unruptured Brain Arteriovenous malformations) in adults has demonstrated that medical management alone is superior in patients with unruptured AVMs,25 but there is insufficient scientific evidence to justify extrapolation of these results to a paediatric population. Moreover, while it has been shown that paediatric AVMs with haemorrhagic presentation do not necessarily have a higher risk of future haemorrhage nor a higher annualised bleeding risk than adults,26 their greater cumulative risk given their longer remaining life expectancy may be an argument for more aggressive treatment of paediatric AVMs. Choice of treatment for a small, unruptured paediatric AVM is therefore complex and should involve thorough consideration of other angioarchitectural factors on a case-by-case basis.
 
Despite these limitations, our study provides useful initial insights to the angiographic features associated with haemorrhagic presentation of AVMs in Chinese paediatric patients from multiple locoregional neurosurgical centres. These features may assist in stratifying risk of haemorrhage and assign priority for intervention, although data from future larger-scale studies may be needed before such features can be robustly applied as haemorrhagic risk predictors in Chinese children with AVM.
 
References
1. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990;73:387-91. Crossref
2. Choi JH, Mohr JP. Brain arteriovenous malformations in adults. Lancet Neurol 2005;4:299-308. Crossref
3. Freidlander RM. Clinical practice. Arteriovenous malformations of the brain. N Engl J Med 2007;356:2704-12. Crossref
4. Hofmeister C, Stapf C, Hartmann A, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke 2000;31:1307-10. Crossref
5. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their clinical history. J Neurosurg 1983;58:331-7. Crossref
6. Jordan LC, Hillis AE. Hemorrhagic stroke in children. Pediatr Neurol 2007;36:73-80. Crossref
7. Meyer-Heim AD, Boltshauser E. Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev 2003;25:416-21. Crossref
8. Giroud M, Lemesle M, Madinier G, Manceau E, Osseby GV, Dumas R. Stroke in children under 16 years of age. Clinical and etiological difference with adults. Acta Neurol Scand 1997;96:401-6. Crossref
9. Stefani MA, Porter PJ, terBrugge KG, Montanera W, Willinsky RA, Wallace MC. Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke 2002;33:920-4. Crossref
10. Turjman F, Massoud TF, Viñuela F, Sayre JW, Guglielmi G, Duckwiler G. Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery 1995;37:856-60; discussion 860-2. Crossref
11. Nataf F, Meder JF, Roux FX, et al. Angioarchitecture associated with haemorrhage in cerebral arteriovenous malformations: a prognostic statistical model. Neuroradiology 1997;39:52-8. Crossref
12. Ellis MJ, Armstrong D, Vachhrajani S, et al. Angioarchitectural features associated with hemorrhagic presentation in pediatric cerebral arteriovenous malformations. J Neurointerv Surg 2013;5:191-5. Crossref
13. Di Rocco C, Tamburrini G, Rollo M. Cerebral arteriovenous malformations in children. Acta Neurochir (Wien) 2000;142:145-56; discussion 156-8. Crossref
14. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet 2002;359:863-73. Crossref
15. Kim H, Stephen S, McChulloch, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke 2007;38:2430-7. Crossref
16. Farhat HI. Cerebral arteriovenous malformations. Dis Mon 2011;57:625-37. Crossref
17. Spetzler RF, Hargraves RW, McCormick PW, Zabramski JM, Flom RA, Zimmerman RS. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg 1992;76:918-23. Crossref
18. Crawford PM, West CR, Chadwick DW, Shaw MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 1986;49:1-10. Crossref
19. Guidetti B, Delitala A. Intracranial arteriovenous malformations. Conservative and surgical treatment. J Neurosurg 1980;53:149-52. Crossref
20. Itoyama Y, Uemura S, Ushio Y, et al. Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases. J Neurosurg 1989;71:805-9. Crossref
21. Pollock BE, Flickinger JC, Lunsford LD, Bissonette DJ, Kondziolka D. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke 1996;27:1-6. Crossref
22. da Costa L, Wallace MC, Ter Brugge KG, O’Kelly C, Willinsky RA, Tymianski M. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 2009;40:100-5. Crossref
23. Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66:1350-5. Crossref
24. Blauwblomme T, Bourgeois M, Meyer P, et al. Long-term outcome of 106 consecutive pediatric ruptured brain arteriovenous malformations after combined treatment. Stroke 2014;45:1664-71. Crossref
25. Mohr JP, Parides MK, Stapf C, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614-21. Crossref
26. Fullerton HJ, Achrol AS, Johnston SC, et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 2005;36:2099-104. Crossref

Clinical value of transforaminal epidural steroid injection in lumbar radiculopathy

Hong Kong Med J 2015 Oct;21(5):394–400 | Epub 14 Aug 2015
DOI: 10.12809/hkmj144310
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Clinical value of transforaminal epidural steroid injection in lumbar radiculopathy
SM Leung, MMed(Pain Mgt)(Syd), FHKAM (Orthopaedic Surgery)1,2; WW Chau, MSc (Epi & Biostat)3; SW Law, MOM, FHKAM (Orthopaedic Surgery)1,2,4; KY Fung, MB, BS, FHKAM (Orthopaedic Surgery)1,2,4
1 Department of Orthopaedics and Traumatology, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong
2 Department of Orthopaedic Rehabilitation, Tai Po Hospital, Tai Po, Hong Kong
3 Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong
4 Department of Orthopaedics and Traumatology, Prince of Wales Hospital, Shatin, Hong Kong
Corresponding author: Dr SM Leung (lsm457@ha.org.hk)
 
 Full paper in PDF
 
Abstract
Objectives: To identify the diagnostic, therapeutic, and prognostic values of transforaminal epidural steroid injection as interventional rehabilitation for lumbar radiculopathy.
 
Design: Case series.
 
Setting: Regional hospital, Hong Kong.
 
Patients: A total of 232 Chinese patients with lumbar radiculopathy attributed to disc herniation or spinal stenosis received transforaminal epidural steroid injection between 1 January 2007 and 31 December 2011.
 
Interventions: Transforaminal epidural steroid injection.
 
Main outcome measures: Patients’ immediate response, response duration, proportion of patients requiring surgery, and risk factors affecting the responses to transforaminal epidural steroid injection for lumbar radiculopathy.
 
Results: Of the 232 patients, 218 (94.0%) had a single level of radiculopathy and 14 (6.0%) had multiple levels. L5 was the most commonly affected level. The immediate response rate to transforaminal epidural steroid injection was 80.2% in 186 patients with clinically diagnosed lumbar radiculopathy and magnetic resonance imaging of the lumbar spine suggesting nerve root compression. Of patients with single-level radiculopathy and multiple-level radiculopathy, 175 (80.3%) and 11 (78.6%) expressed an immediate response to transforaminal epidural steroid injection, respectively. The analgesic effect lasted for 1 to <3 weeks in 35 (15.1%) patients, for 3 to 12 weeks in 37 (15.9%) patients, and for more than 12 weeks in 92 (39.7%) patients. Of the 232 patients, 106 (45.7%) were offered surgery, with 65 (61.3%) undergoing operation, and with 42 (64.6%) requiring spinal fusion in addition to decompression surgery. Symptom chronicity was associated with poor immediate response to transforaminal epidural steroid injection, but not with duration of pain reduction. Poor response to transforaminal epidural steroid injection was not associated with a preceding industrial injury.
 
Conclusions: The immediate response to transforaminal epidural steroid injection was approximately 80%. Transforaminal epidural steroid injection is a useful diagnostic, prognostic, and short-term therapeutic tool for lumbar radiculopathy. Although transforaminal epidural steroid injection cannot alter the need for surgery in the long term, it is a reasonably safe procedure to provide short-term pain relief and as a preoperative assessment tool.
 
 
New knowledge added by this study
  • This is the first local study to evaluate the clinical value of transforaminal epidural steroid injection (TFESI) as an alternative to or antecedent procedure for definitive spinal surgery.
Implications for clinical practice or policy
  • TFESI is a reasonably safe diagnostic and therapeutic option as interventional rehabilitation for lumbar radiculopathy.
 
 
Introduction
Lumbar radiculopathy can be well-managed conservatively in the primary health care setting, but many patients with persistent disabling radicular pain need attention in a specialty clinic. The majority of patients first attend a public specialty clinic in Hong Kong with pain chronicity of more than 12 months, as they have had no significant clinical response to conservative management in primary health care, private medical specialists, traditional Chinese medicine, or alternative medicine, and they anticipate a long waiting time in a public hospital. Epidural steroid injection is commonly practised by orthopaedic surgeons, neurosurgeons, rehabilitation specialists, pain specialists, and interventional radiologists worldwide. The thresholds for offering epidural steroid injection by clinicians and acceptance by patients are variable, however.
 
Transforaminal epidural steroid injection (TFESI) is one of the more common approaches of epidural steroid injection, along with the interlaminar and caudal approaches. The technique is target-specific and the best route for delivering medication to the ventral epidural space (Fig 1a) and dorsal root ganglion,1 where most pathological changes occur.2 3 The least amount of drug with a relatively higher drug concentration is required to reach the primary site of pathology compared with interlaminar and caudal epidural steroid injections.4
 

Figure 1. Epidural flow of water-soluble non-ionic contrast to reach ventral epidural space as shown in (a) lateral and (b) anteroposterior views; (c) the L4 exiting nerve root is well-outlined by the contrast (arrows)
 
Transforaminal epidural steroid injection is a useful procedure for lumbar radiculopathy.5 The technique provides neural blockade to anaesthetise the target nerve root for diagnostic purposes, and interrupts nociceptive input and self-sustaining activity of the neurons. Steroid provides anti-inflammatory effect (inhibition of pro-inflammatory synthesis and release of mediators) and produces longer-term pain relief, primarily for radiculopathy. The prognostic value of TFESI for surgical outcomes has been reported, with better surgical outcome in TFESI responders with chronic lumbar radiculopathy than in non-responders.6 The technique, however, does not alter the ultimate need for surgery.7
 
Underlying sepsis, malignant disease, and coagulopathy are considered to be contra-indications for spinal injection. The perceived benefits and threshold of offering TFESI as an adjunct to conservative treatment for patients with lumbar radiculopathy attributed to disc herniation or spinal stenosis are variable among orthopaedic surgeons, rehabilitation specialists, and pain specialists. The objective of this study was to identify the diagnostic, therapeutic, and prognostic values of TFESI for lumbar radiculopathy in Chinese patients in Hong Kong.
 
Methods
Procedural steps for transforaminal epidural steroid injection
Patients were placed in the prone position on a radiolucent operating table. A 22-G spinal needle was inserted into the target neuroforamen with fluoroscopic image guidance. The target nerve root and its epidural space were outlined by water-soluble non-ionic contrast, ensuring epidural flow of contrast with no intravascular, intradural, or subcutaneous infiltration (Fig 1). A mixture of 1-mL methylprednisolone acetate 40 mg and 1-mL bupivacaine 0.5% was injected. Finally, the intact spinal needle was removed.
 
Data collection and analysis
All patients who received TFESI for lumbar radiculopathy at Alice Ho Miu Ling Nethersole Hospital, Hong Kong from 1 January 2007 to 31 December 2011 (5 years) were identified by the electronic medical record system in the hospital. Retrospective review of all the medical records identified patients with numeric pain rating scale score (NPRS) of 4 to 7 (out of 10) who took less than three types of analgesics for at least 8 weeks as conservative treatment, or patients with persistent disabling pain with NPRS of >7 despite taking more than three types of analgesics for at least 1 week as conservative treatment. Patients with NPRS of <4, missing record of post-procedure response, or who had received previous lumbar spinal injection and lumbar spinal surgery were excluded.
 
The first part of the study assessed the response rate to diagnostic block by the local anaesthetic effect of TFESI for all patients with a clinical diagnosis of lumbar radiculopathy attributed to disc herniation or spinal stenosis, with compatible magnetic resonance imaging (MRI) findings of laterality and affected level. The second part of the study assessed the therapeutic and prognostic values of the steroid effect of TFESI as an adjunct to conservative treatment prior to assessment of surgical need.
 
The threshold for surgery for patients with lumbar radiculopathy attributed to prolapsed intervertebral disc (PID) and spinal stenosis, in general, considered factors of disabling pain resulting in inability to meet activity demands, clinical MRI findings compatible for laterality and site of compression, and medical fitness for general anaesthesia and major spinal surgery. Spinal fusion might be considered for patients with concomitant spondylolisthesis with instability or anticipated instability resulting from optimal surgical decompression in the lateral recess or foraminal stenosis and concomitant disabling discogenic low back pain that has not responded to conservative treatment.
 
An immediate response on the procedure day was considered to have a positive diagnostic value. Patients who reported pain reduction of greater than 50% at the first follow-up visit 4 weeks after TFESI were considered to have a positive therapeutic response to the steroid effects. The response duration, proportion of patients finally requiring surgery, whether decompression alone or spinal fusion besides decompression was needed, and risk factors that affected the response to TFESI were retrospectively reviewed.
 
Comparisons were carried out for all patients, as well as patients with PID or spinal stenosis only. Associations between responses to TFESI and risk factors for symptom chronicity and industrial injury were done by Fisher’s exact test or Mann-Whitney U test where appropriate. Non-parametric tests were done because some continuous variables were not normally distributed. The Statistical Package for the Social Sciences Windows version 20.0 (SPSS Inc, Chicago [IL], US) was used for all statistical analysis. A two-sided P value of ≤0.05 was considered statistically significant.
 
Results
A total of 241 patients were recruited into this study. Nine patients were excluded for the following reasons: TFESI responders with PID and L5 radiculopathy had had symptom duration of less than 1 week and TFESI was not considered to be adequate first-line conservative treatment (n=3); and TFESI immediate responders did not return for first follow-up (n=2) and TFESI responses were not documented in the medical records (n=4) so the response durations for these six patients could not be verified. Therefore, the total number of eligible participants was 232 (110 men and 122 women; mean age ± standard deviation [SD]: 55.6 ± 14.3 years). The mean age of patients with PID and spinal stenosis were 37.4 ± 7.5 years and 60.3 ± 11.7 years, respectively. The symptom chronicity ranged from 8 days to 23 years with a median of 12.0 months, as well as 25th, 75th, and 90th percentiles being 7.0, 36.0, and 60.0 months, respectively in patients with lumbar radiculopathy. No statistically significant difference (P=0.402) in symptom chronicity between the PID and spinal stenosis groups was noted (median [interquartile range] duration: PID group 12.0 [8.0-24.0] months vs spinal stenosis group 12.0 [6.0-36.0] months). Fewer PID patients (n=48; 20.7%) needed TFESI than spinal stenosis patients (n=184; 79.3%) with lumbar radiculopathy in the study period.
 
L5 was the most commonly affected level of radiculopathy (n=150; 64.7%) regardless of whether a patient had single or multiple levels or underlying pathology of PID or spinal stenosis (Table 1). Therefore, post-ganglionic block of the L5 nerve root by L5-S1 TFESI was most commonly done.
 

Table 1. Level of radiculopathy
 
Diagnostic value of transforaminal epidural steroid injection
The immediate response rate to TFESI was 80.2% in 186 patients with clinically diagnosed lumbar radiculopathy and MRI of the lumbar spine suggesting nerve root compression. Overall, 218 (94.0%) patients were affected at a single level and 14 (6.0%) were affected at multiple levels (Table 1). The immediate response rates to TFESI were 175 (80.3%) in the single-level radiculopathy group and 11 (78.6%) in the multiple-level radiculopathy group. There was no statistically significant difference in the immediate responder rate between patients with PID or spinal stenosis (P=0.877). No complications were reported.
 
Predictive value for final need for surgery
The final need for surgery of TFESI immediate responders was noted in 10/39 (25.6%) patients in the PID group and 43/147 (29.3%) patients in the spinal stenosis group (Table 2).
 

Table 2. Proportion of patients requiring surgery in different response and pathology groups (n=232)
 
Of the 232 patients, 106 (45.7%) were offered surgery, of whom 65 (61.3%) accepted surgery. The mean time from TFESI to uptake of surgery was 7.9 months. There was a statistically significant shorter median time to definitive surgery in the PID group (10.0 months) than in the spinal stenosis group (19.2 months) [P<0.01]. This reflects the fact that PID patients with failed first-line conservative treatment who needed TFESI for lumbar radiculopathy were likely to accept surgery earlier than patients with spinal stenosis. Patients with PID were younger (mean age, 37.0 years) than spinal stenosis patients (mean age, 59.2 years) undergoing surgery, which might be related to less daily activity demand, higher perceived operative risks, and older people being more psychologically reluctant to undergo surgery.
 
Of the 65 surgical patients, 23 (35.4%) underwent decompression surgery alone, with a mean time from TFESI of 5.45 months (SD, 5.25 months; median, 3.6 months; range, 8 days to 17.63 months). The remaining 42 (64.6%) patients required spinal fusion in addition to decompression surgery, with a mean time from TFESI of 9.37 months (SD, 7.23 months; median, 7.22 months; range, 14 days to 25.33 months). The difference in time to surgery for these two groups was statistically significant (P=0.012). More patients with a short-term response to TFESI underwent surgery (Fig 2) and TFESI was commonly used as a preoperative assessment tool.
 

Figure 2. Response duration according to the final surgery rate
 
Association between response to transforaminal epidural steroid injection and duration of pain relief
The analgesic effect of TFESI lasted for less than 1 week (poor response) in 68 (29.3%) patients, for 1 to <3 weeks (short term) in 35 (15.1%) patients, for 3 to 12 weeks (intermediate) in 37 (15.9%) patients, and for more than 12 weeks (long term) in 92 (39.7%) patients. More patients with spinal stenosis underwent surgery in the short-term pain reduction group (1-<3 weeks), and the association between response to TFESI and surgery for spinal stenosis was significant (P<0.01), but no significance was noted for PID patients (P=0.067) [Table 3].
 

Table 3. Association between response to TFESI, pain relief duration, and final surgery
 
Association between poor response to transforaminal epidural steroid injection and chronicity of symptoms and industrial injury
Poor response (mean, 34.3 ± 50.9 months) to TFESI (no immediate response and pain reduction duration of <1 week) was significantly associated with chronicity of symptoms (vs 23.1 ± 28.3 months in patients with positive response) [P=0.047]. Pain reduction duration had no significant association with symptom chronicity for pain reduction of less than 3 months and 3 months or more in the PID (P=0.225) and spinal stenosis (P=0.250) groups (Table 4).
 

Table 4. Association between symptom chronicity and TFESI response pattern in PID and spinal stenosis groups
 
There was no association between response to TFESI and industrial injury for all eligible patients (P=0.138) and no significant association according to the underlying cause of PID (P=0.359) and spinal stenosis (P=0.469) [Table 5].
 

Table 5. Association between the response to TFESI and industrial injury
 
Discussion
The decision by clinicians to offer a treatment and by patients to accept it is often determined by the perceived benefits, likelihood of success, and the cost (eg risks, time cost, labour cost, and financial cost) of the treatment. In real-world clinical practice, there are large variations in the perceived benefits and likelihood of success of TFESI among clinicians despite its relatively fewer risks and lower cost than spinal surgery. This retrospective case review attempted to show real-life practice in a local unit during a fixed period to evaluate the diagnostic, prognostic, and therapeutic values.
 
Lumbar radiculopathy can be well managed conservatively, but many patients still have persistent disabling radicular pain needing attention in a specialty clinic. Most patients first attended a public specialty clinic with chronicity of more than 12 months because of no significant clinical response to conservative management. Most patients receiving spinal injection have had a lengthy period of trying various modalities of conservative treatments, reflected by a median time of 12 months of symptom chronicity for patients receiving TFESI.
 
The threshold of offering TFESI as a diagnostic tool and/or a therapeutic adjunct to conservative treatment is variable among clinicians, reflected by the wide variation of symptom chronicity from 8 days to 23 years among the 232 patients receiving TFESI in this study. Other factors affecting the threshold of offering TFESI include severe neuropathic pain not controlled by more than three kinds of high-dose analgesic combinations that act on different pain pathways, and the diagnostic need for doubtful clinical MRI correlations, especially among patients contemplating surgery or who are undergoing a pain relief procedure while waiting for definitive surgery in a local public hospital.
 
L5 radiculopathy was the most commonly affected level, regardless of whether single or multiple levels were affected, in patients with PID or spinal stenosis in this series. Post-ganglionic block of the L5 nerve root by L5-S1 TFESI was commonly performed.
 
The clinical presentation of lumbar radiculopathy without significant neurocompression on MRI scan might be related to chemical irritation by local inflammation from an annular tear rather than significant mechanical compression to the nerve root. These patients can be treated conservatively or by TFESI. Sometimes, dynamic spinal stenosis as a result of an incompetent degenerative disc with loss of disc height and its support of the spinal load or spondylolisthesis with spinal instability might be worsened in the upright posture, and might not be well demonstrated in MRI of the lumbar spine taken in the supine position. The technique of TFESI is a target-specific diagnostic tool to the affected nerve root. The procedure increases the diagnostic confidence of clinical lumbar radiculopathy before both the patient and surgeon commit to more invasive surgical interventions, especially for a clinical diagnosis of lumbar radiculopathy with doubtful correlation to MRI findings.
 
As demonstrated in this study, TFESI is a target-specific diagnostic tool with up to 80% immediate response for lumbar radiculopathy. An immediate pain response is expected to be related to the local anaesthetic effect acting on the affected nerve root and its dorsal root ganglion, washout effects of injectates on the chemical irritation of the local inflammatory mediators or, occasionally, on the loose extraforaminal sequestrated disc material. The pain reduction duration is expected to be related to the anti-inflammatory effect of steroid. However, it is not expected to change the anatomy, which is due to significant mechanical compression to the affected nerve root. This often needs to be managed surgically so the results of TFESI cannot alter the final need for surgery.
 
Patients commonly enquire whether TFESI is an alternative or antecedent procedure to definitive spinal surgery. There is strong evidence to support the use of lumbar TFESI in patients with acute-to-subacute unilateral radicular pain caused by herniated nucleus pulposus or spinal stenosis.8 9 Nonetheless, there is no relief of pain in patients with chronic failed back surgery syndrome and documented fibrosis of the nerves.2
 
Chronic pain and industrial injury generally have less favourable responses to many treatments. This study showed significant differences in symptom chronicity and poor immediate response rate to TFESI (P=0.047), but failed to show a statistically significant association between symptom chronicity and TFESI response duration in lumbar radiculopathy attributed to PID (P=0.225) or spinal stenosis (P=0.250) [Table 4]. The diagnostic value of TFESI is more prominent than the therapeutic value in chronic lumbar radiculopathy in both the PID and spinal stenosis groups. A preceding history of industrial injury was not associated with TFESI response difference in lumbar radiculopathy attributed to PID (P=0.359) or spinal stenosis (P=0.469) [Table 5]. Therefore, industrial injury is not a limitation in consideration of offering TFESI.
 
As demonstrated in this study, most patients (80.2%) with lumbar radiculopathy attributed to PID or spinal stenosis were managed by non-surgical treatments. Less than one-half of patients (45.7%, 106/232) were offered surgery and only 65 (61.3%) of 106 patients accepted surgery. The technique of TFESI is a reasonable therapeutic trial as an alternative procedure, especially in older frail patients with multiple medical co-morbidities and high peri-operative risks. There were no complications related to the injected medication or needle placement in this series. The technique is a reasonable, safe procedure provided that there is radiographic verification of epidural flow of water-soluble non-ionic contrast with no intravascular, intradural, or subcutaneous infiltration.10
 
Nonetheless, there was still a sizable proportion of patients (45.6%) who underwent surgery for persistent disabling pain when there was clinical MRI–compatible neurocompression. The mean time to surgery from TFESI was 7.9 months. The technique of TFESI helps give time for better quality of pain relief, but it does not affect the ultimate need of surgery, especially for patients who require spinal fusion for spinal instability, either anticipated preoperatively or after surgical decompression. Among the 186 immediate responders, up to 10 (25.6%) of 39 in the PID group and 43 (29.3%) of 147 in the spinal stenosis group required surgery (Table 2). Although TFESI is unable to correct structural pathology, it is a reasonable antecedent procedure to definitive surgical decompression. The technique provides 80.2% immediate response, thus increasing the diagnostic confidence and providing short-term pain reduction enabling patients to remain active with reduced analgesic consumption and associated systemic side-effects while awaiting definitive spinal surgery. In addition, TFESI provides a better quality of pain relief to help maintain functional independence and to reduce hospital stay. The procedure has a reasonably good diagnostic utility and cost-effectiveness in patients considered for lumbar decompression surgery.11
 
A limitation of this retrospective case review is that the results were based on subjective self-reported pain response, because a more objective functional assessment was not always available in the patients’ medical records. A prospective controlled trial is warranted in the future to obtain more comprehensive information about the change in patients’ daily function in relation to pain reduction.
 
Conclusions
L5 radiculopathy is the most commonly affected level of lumbar radiculopathy. The local anaesthetic effect of TFESI is a useful diagnostic adjunct, with up to 80.2% immediate response in patients with lumbar radiculopathy. Although TFESI cannot alter the need for spinal surgery, it is a reasonably safe procedure to provide short-term pain relief to allow patients to stay active with reduced analgesic consumption and associated systemic side-effects while awaiting surgery.
 
Declaration
The authors do not have any conflicts of interest to declare.
 
References
1. Bhargava A, DePalma MJ, Ludwig S, Gelb D, Slipman CW. Injection therapy for lumbar radiculopathy. Curr Opin Orthop 2005;16:152-7. Crossref
2. Rho ME, Tang CT. The efficacy of lumbar epidural steroid injections: transforaminal, interlaminar, and caudal approaches. Phys Med Rehabil Clin N Am 2011;22:139-48. Crossref
3. Roberts ST, Willick SE, Rho ME, Rittenberg JD. Efficacy of lumbosacral transforaminal epidural steroid injections: a systematic review. PM R 2009;1:657-68. Crossref
4. Abdi S, Datta S, Trescot AM, et al. Epidural steroids in the management of chronic spinal pain: a systematic review. Pain Physician 2007;10:185-212.
5. Botwin KP, Gruber RD, Bouchlas CG, et al. Fluoroscopically guided lumbar transformational epidural steroid injections in degenerative lumbar stenosis: an outcome study. Am J Phys Med Rehabil 2002;81:898-905. Crossref
6. Derby R, Kine G, Saal JA, et al. Response to steroid and duration of radicular pain as predictors of surgical outcome. Spine (Phila Pa 1976) 1992;17(6 Suppl):S176-83. Crossref
7. Wilson-MacDonald J, Burt G, Griffin D, Glynn C. Epidural steroid injection for nerve root compression. A randomised, controlled trial. J Bone Joint Surg Br 2005;87:352-5. Crossref
8. Karppinen J, Malmivaara A, Kurunlahti M, et al. Periradicular infiltration for sciatica: a randomized controlled trial. Spine (Phila Pa 1976) 2001;26:1059-67. Crossref
9. Ng L, Chaudhary N, Sell P. The efficacy of corticosteroids in periradicular infiltration for chronic radicular pain: a randomized, double blind, controlled trial. Spine 2005;30:857-62. Crossref
10. Ptaszynski A, Huntoon M. Complications of spinal injections. Tech Reg Anesth Pain Manag 2007;11:122-32. Crossref
11. Beynon R, Hawkins J, Laing R, Higgins N, Whiting P. The diagnostic utility and cost-effectiveness of selective nerve root blocks in patients considered for lumbar decompression surgery: a systematic review and economic model. Health Technol Assess 2013;17:88. Crossref

Paracetamol overdose in Hong Kong: is the 150-treatment line good enough to cover patients with paracetamol-induced liver injury?

Hong Kong Med J 2015 Oct;21(5):389–93 | Epub 31 Jul 2015
DOI: 10.12809/hkmj144481
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE    CME
Paracetamol overdose in Hong Kong: is the 150-treatment line good enough to cover patients with paracetamol-induced liver injury?
Simon TB Chan, MB, BS1; CK Chan, Dip Clin Tox, FHKAM (Emergency Medicine)2; ML Tse, FHKCEM, FHKAM (Emergency Medicine)2
1 Department of Accident and Emergency, United Christian Hospital, Kwun Tong, Hong Kong
2 Hong Kong Poison Information Centre, United Christian Hospital, Kwun Tong, Hong Kong
Corresponding author: Dr Simon TB Chan (ctb021@ha.org.hk)
 
 Full paper in PDF
Abstract
Objectives: To evaluate the failure rate of the 150-treatment line for paracetamol overdose in Hong Kong, and the impact if the treatment threshold was lowered.
 
Design: Case series.
 
Setting: Public hospitals, Hong Kong.
 
Patients: All patients with acute paracetamol overdose reported to the Hong Kong Poison Information Centre from 1 January 2011 to 31 December 2013 were studied and analysed for the timed serum paracetamol concentration and their relationship to different treatment lines. Presence of significant liver injury following paracetamol overdose was documented. The potential financial burden of different treatment lines implemented locally was estimated.
 
Results: Of 893 patients, 187 (20.9%) had serum paracetamol concentration above the 150-treatment line, 112 (12.5%) had serum paracetamol concentration between the 100- and 150-treatment lines, and 594 (66.5%) had serum paracetamol level below the 100-treatment line. Of the 25 (2.8%) patients who developed significant liver injury, two were between the 100- and 150-treatment lines, and the other two were below the 100-treatment line. The failure rate of the 150-treatment line was 0.45%. Lowering the treatment threshold to the 100-treatment line might lower the failure rate of the treatment nomogram to 0.22% but approximately 37 more patients per year would need to be treated. It would incur an additional annual cost of HK$189 131 (US$24 248), and an additional 1.83 anaphylactoid reactions per year. The number needed-to-treat to potentially reduce one significant liver injury is 112.
 
Conclusions: Lowering the treatment threshold of paracetamol overdose may reduce the treatment-line failure rate. Nonetheless such a decision must be balanced against the excess in treatment complications and health care resources.
 
 
New knowledge added by this study
  • For paracetamol overdose in Hong Kong, the failure rate of the 150-treatment line is 0.45%. Lowering the treatment threshold to 100-treatment line may lower the failure rate to 0.22%.
  • Implementing the 100-treatment line in Hong Kong would incur an annual cost of HK$189 131 (US$24 248), 37 more patients per year needing treatment, and an additional 1.83 anaphylactoid reactions per year. The number needed-to-treat to potentially reduce one significant liver injury is 112.
Implications for clinical practice or policy
  • Clinicians should be aware of the chance of treatment-line failure in patients with acute paracetamol overdose.
  • Recommendations for the treatment threshold for acute paracetamol overdose may be evaluated together with the clinical and financial impacts described in this study.
 
 
Introduction
Paracetamol is a common analgesic and antipyretic, and is currently the most commonly overdosed therapeutic agent in Hong Kong, accounting for 8.4% of all poisoning cases.1 After the first human case report of paracetamol-induced liver injury in 1966,2 paracetamol overdose remains an important cause of acute liver failure with mortalities worldwide. The efficacy of N-acetylcysteine (NAC) in the treatment and prevention of paracetamol-induced liver injury has been established over the last decades.3 4 In acute paracetamol overdose, serum paracetamol concentration measured at 4 to 24 hours post-ingestion (timed serum paracetamol concentration) is plotted on the Rumack-Matthew nomogram. Treatment with NAC should be initiated if the serum paracetamol concentration is plotted on or above the treatment line.5 Different treatment lines exist, however, and there is no worldwide consensus on the safest serum paracetamol concentration at which to initiate NAC treatment.
 
In the United States, the timed serum paracetamol concentration is plotted against a single treatment line starting at 150 mg/L at 4 hours post-ingestion (150-treatment line).6 Patients with serum paracetamol concentration above this line are treated with NAC. This line was imposed by the United States Food and Drug Administration with a 25% safety margin based on the work of Rumack in 1975,5 and was also adopted in Australia and New Zealand.7
 
Previously in the United Kingdom, two different treatment lines were used. Patients were categorised into ‘normal risk’ or ‘high risk’ according to their medical and behavioural background. Those patients with possible glutathione depletion, for example with malnutrition or chronic heavy alcoholism, were considered ‘high risk’ while the remaining patients were considered ‘normal risk’. Treatment lines starting at 200 mg/L (200-treatment line) and 100 mg/L (100-treatment line) at 4 hours post-ingestion were used in patients with ‘normal risk’ and ‘high risk’, respectively.
 
The Medicines and Healthcare products Regulatory Agency of the United Kingdom lowered the threshold of NAC treatment in 2012,8 following a series of patients with severe liver injury and several mortalities after paracetamol overdose were reported to have a serum paracetamol concentration below the level dictated by the previous treatment protocol.9 All patients in the United Kingdom with serum paracetamol concentration over the 100-treatment line are now prescribed NAC treatment.
 
The Hong Kong Poison Information Centre (HKPIC) currently recommends intravenous NAC treatment in patients with serum paracetamol concentration above the 150-treatment line. One course of NAC treatment typically takes 21 hours of intravenous infusion in hospital under close observation. In this study, we examined a series of non-staggered acute paracetamol overdose cases in Hong Kong to determine how well the current 150-treatment line can cover patients with paracetamol-induced liver injury and the impact on the local health care system if the treatment threshold is changed.
 
Methods
We performed a retrospective observational study by reviewing patients with acute paracetamol overdose who presented to 16 emergency departments (EDs) in public hospitals in Hong Kong between 1 January 2011 and 31 December 2013. Data were retrieved from the electronic database of the HKPIC and electronic Patient Record of the Hospital Authority. All patients aged 12 years or above with acute paracetamol overdose were included.
 
In this study, acute paracetamol overdose was defined as ingestion of paracetamol or paracetamol-containing medications in a single attempt. As some patients intentionally took a large number of tablets, we allowed a maximum duration of ingestion process for up to 1 hour. When the ingestion process occurred over 1 hour, the overdose was considered to be staggered and such patients were excluded from the study. Patients were also excluded if time of ingestion was undetermined, no serum paracetamol concentration was available within 4 to 24 hours post-ingestion, or patients presented to EDs more than 24 hours post-ingestion.
 
The following data were collected: clinical profile including age, sex, first serum paracetamol concentration between 4 and 24 hours post-ingestion, treatment given, and the presence of significant liver injury during the episode. Significant liver injury was defined as serum alanine aminotransferase (ALT) level of ≥1000 IU/L in the absence of a known history of deranged liver function.
 
Results
There were a total of 1243 patients with acute paracetamol overdose within the study period. Exclusions included 73 patients with staggered overdose, 137 patients with undetermined time of paracetamol ingestion, 100 patients with no serum paracetamol concentration available within 4 to 24 hours of ingestion, and 40 patients who presented to the EDs of >24 hours post-ingestion. Data on 893 patients who fulfilled the inclusion criteria were analysed. The clinical data of the studied patients are presented in Table 1.
 

Table 1. Clinical data of patients with acute paracetamol overdose (n=893)
 
No deaths occurred in the study population and no patient required liver transplantation. There were 187 (20.9%) patients with a serum paracetamol concentration above the 150-treatment line, 112 (12.5%) patients had a serum paracetamol concentration between the 100- and 150-treatment lines, and the remaining 594 (66.5%) patients had serum paracetamol concentration below the 100-treatment line.
 
Significant liver injury occurred in 25 patients within the study period, giving an overall incidence of 2.8% following acute paracetamol overdose (Table 2). Four patients with serum paracetamol concentration below the 150-treatment line developed significant liver injury. The failure rate of the 150-treatment line was 0.45% (4/893). If 100-treatment line is applied instead of 150-treatment line, two patients with serum paracetamol concentration below the 100-treatment line developed significant liver injury. The failure rate of the 100-treatment line would thus be 0.22% (2/893).
 

Table 2. Serum paracetamol concentration and the incidence of significant liver injury
 
Discussion
Paracetamol overdose is a commonly encountered problem in Hong Kong, and is the single most common cause of poisoning. According to the Rumack-Matthew nomogram, a serum paracetamol concentration starting from 200 mg/L at 4 hours is associated with an increased risk of liver injury and death.10 The clinical decision to commence treatment with NAC is dictated by the timed serum paracetamol concentration plotted against the nomogram with a treatment line. If the timed serum paracetamol concentration is above the treatment line, NAC treatment is indicated. Based on different considerations, for example the accuracy of clinical history and individual susceptibility, different treatment lines are applied by different countries or centres to guide initiation of NAC treatment.
 
Since the United Kingdom lowered the NAC treatment threshold to the 100-treatment line,8 there has been discussion in Hong Kong about the benefit of changing local recommendations. Nonetheless, it is unknown whether the reasons for changing the recommendation in the United Kingdom apply to the Hong Kong population. This study serves to provide more information for further discussion and consideration.
 
We were most interested to identify patients who developed significant liver injury following paracetamol overdose in which the serum paracetamol concentration was lower than the treatment line. In the 3-year study period, four patients with a paracetamol concentration below the 150-treatment line developed significant liver injury. These cases are discussed in detail below and summarised in Table 3.
 

Table 3. Details of patients with significant liver injury below the 150-treatment line
 
Case 1
A 36-year-old woman with known depressive disorder attended the ED 20.5 hours following ingestion of 100 tablets of paracetamol. She had abdominal pain afterwards. On presentation, the paracetamol concentration was 43 µmol/L (6.5 mg/L). This level falls between the 100- and 150-treatment lines. The level of ALT was 53 IU/L and international normalised ratio (INR) was 1.03. She was admitted to the medical ward. Although her serum paracetamol concentration plotted below the 150-treatment line, NAC treatment was given soon after admission based on the clinical features of hepatitis. Her liver enzyme level started to elevate the next day with clinical jaundice, and on day 2 of admission her ALT level peaked at 3232 IU/L, and INR at 1.43 with bilirubin level of 45 µmol/L. She was treated conservatively and liver function gradually improved. She was discharged on day 6 of admission.
 
Case 2
A 31-year-old woman attempted suicide by ingesting around 50 tablets of over-the-counter drugs. She was brought to the ED 3 hours afterwards and complained of mild dizziness and nausea. Activated charcoal 50 g was given and she was admitted to the Intensive Care Unit (ICU). Serum paracetamol concentration taken at 7 hours post-ingestion was 418 µmol/L (63.3 mg/L), between the 100- and 150-treatment lines. The patient was treated supportively in the ICU for the first day. At 24-hour post-ingestion her ALT level was 48 IU/L, INR was 1.3, and at 29 hours post-ingestion the ALT level elevated to 73 IU/L, with INR of 1.4. Intravenous NAC treatment was commenced 30 hours post-ingestion. Liver function continued to deteriorate: ALT level peaked at 4655 IU/L and INR peaked at 1.5 on day 3 of admission. The serum bilirubin level was 67 µmol/L. She had clinical jaundice and vomiting. On day 4, NAC infusion was stopped. She had full recovery of liver function at 1-month follow-up.
 
Case 3
An 18-year-old man ingested around 50 tablets of paracetamol in a suicide attempt. He attended the ED 5 hours later. He was asymptomatic on presentation. Serum paracetamol concentration at 5 hours post-ingestion was 330 µmol/L (49.8 mg/L), below the 100-treatment line. At presentation his ALT level was 64 IU/L and INR was 1.06. Liver function tests repeated at 7 hours post-ingestion showed ALT level was increased to 98 IU/L and INR was 1.3. Intravenous NAC was started. The liver function deterioration peaked at day 3 of admission with ALT level of 2172 IU/L and INR of 1.53 and the patient complained of abdominal pain; NAC infusion was continued until day 5 of admission. His liver function improved and he was transferred to the psychiatric ward for management of depression on day 6. He had full recovery of his liver function.
 
Case 4
A 50-year-old man had flu-like symptoms and fever for 5 days. He ingested 60 tablets of paracetamol in a suicide attempt related to financial stress and physical discomfort. At 20 hours after ingestion, he attended the ED for recurring fever. On presentation his body temperature was 40.2°C. Blood tests revealed ALT level of 511 IU/L, INR of 1.1, and serum paracetamol concentration of 28 µmol/L (4.2 mg/L), below the 100-treatment line at 20.5 hours; NAC treatment was given based on the clinical features of chemical hepatitis. His liver markers peaked the next day with ALT level of 1162 IU/L, INR of 1.2, and with abdominal pain. His fever and respiratory symptoms subsided with a course of intravenous antibiotics. His liver function gradually improved and he was transferred to the psychiatric ward on day 6 after admission.
 
All four patients were considered ‘normal risk’ according to the old United Kingdom classification of treatment line options.
 
Analysis of these four cases revealed that if the NAC treatment threshold had been lowered from the 150-treatment line to 100-treatment line, the treatment line would have covered the first two cases but not the last two. The treatment-line failure rate would thus be reduced by half to 0.22%. A lower failure rate of the treatment line implies that people who will develop liver injury following paracetamol overdose are more likely to receive early treatment with NAC. Although not proven in this study, this should prevent a small number of cases of significant morbidity related to severe paracetamol poisoning.
 
Giving intravenous NAC is not without risk, however. If the 100-treatment line had been applied instead of the 150-treatment line, the number of patients in this study in whom NAC treatment would have been indicated would increase from 187 (20.9%) to 299 (33.5%)—an additional 112 courses of NAC over 3 years. In addition, since 4.9% of the patients given NAC in this study developed an anaphylactoid reaction, there would also have been an additional 5.49 anaphylactoid reactions (1.83 patients/year).
 
The financial burden of treating additional patients with NAC courses can be estimated by additional cost of hospital stay11 and drug cost of NAC, approximately HK$5066 (US$650) per standard 21-hour intravenous NAC administration. This is similar to the estimated cost of a standard NAC course in a United Kingdom study.12 An additional 112 courses of NAC would cost HK$567 392 (US$72 743) within the study period of 3 years with an average of HK$189 131 (US$24 248) per year. The calculations are shown in Table 4. On rare occasions NAC treatment may be extended over 21 hours and result in a further increase in the actual cost.
 

Table 4. Estimation of financial burden for different treatment lines
 
The liver injury in case 2 was judged to have been preventable by timely NAC treatment in nomogram perspective. Thus, we would need to administer NAC to an additional 112 patients to achieve potential benefit in one patient. The number needed-to-treat of lowering 150-treatment line to 100-treatment line to potentially prevent one case of paracetamol-induced liver injury is 112.
 
Despite these data, the clinical decision to initiate NAC treatment may not depend solely on the timed serum paracetamol concentration. As illustrated in case 1, NAC treatments were occasionally initiated based on the patient’s presentation and doctor’s clinical judgement. In our study, 23 of 112 patients with serum paracetamol concentration plotted between 100- and 150-treatment lines were prescribed NAC for similar reasons. Thus if the 100-treatment line is used instead of the 150-treatment line, the actual number of additional NAC treatment that would have been needed is 89 (ie 112-23 cases).
 
Limitations
In the clinical management of paracetamol overdose in Hong Kong, patients may be discharged if their serum paracetamol level is below the treatment line and there are no active clinical symptoms. Although no patient in this study was readmitted for hepatitis, there may have been others who developed chemical hepatitis and who were not brought to our attention. Thus the incidence of liver injury will have been underestimated.
 
Conclusions
Neither the 150- nor 100-treatment line can fully cover all patients who develop significant liver injury following paracetamol overdose. The failure rate of the treatment lines and potential financial burden were studied. This serves as the basis for future considerations of treatment in Hong Kong for paracetamol overdose.
 
References
1. Chan YC, Tse ML, Lau FL. Hong Kong Poison Information Centre: Annual Report 2012. Hong Kong J Emerg Med 2013;20:371-81.
2. Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966;2:497-9. Crossref
3. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979;2:1097-100. Crossref
4. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988;319:1557-62. Crossref
5. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002;40:3-20. Crossref
6. Rowden AK, Norvell J, Eldridge DL, Kirk MA. Updates on acetaminophen toxicity. Med Clin North Am 2005;89:1145-59. Crossref
7. Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA; Panel of Australian and New Zealand clinical toxicologists. Guidelines for the management of paracetamol poisoning in Australia and New Zealand—explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008;188:296-301.
8. Paracetamol overdose: new guidance on use of intravenous acetylcysteine. Commission on Human Medicines, United Kingdom. Available from: https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAttachment.aspx?Attachment_id=101488. Accessed 7 Jul 2015.
9. Beer C, Pakravan N, Hudson M, et al. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. QJM 2007;100:93-6. Crossref
10. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975;55:871-6.
11. Head 140, Expenditure estimates, The 2014-15 Budget, Hong Kong Special Administrative Region, People’s Republic of China. Available from: http://www.budget.gov.hk/2014/eng/pdf/head140.pdf. Accessed 19 Nov 2014.
12. McQuade DJ, Dargan PI, Keep J, Wood DM. Paracetamol toxicity: What would be the implications of a change in UK treatment guidelines? Eur J Clin Pharmacol 2012;68:1541-7. Crossref

Dental luxation and avulsion injuries in Hong Kong primary school children

Hong Kong Med J 2015 Aug;21(4):339–44 | Epub 17 Jul 2015
DOI: 10.12809/hkmj144433
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Dental luxation and avulsion injuries in Hong Kong primary school children
SY Cho, MDS (Otago), FHKAM (Dental Surgery)
MacLehose Dental Centre, G/F, 286 Queen’s Road East, Wanchai, Hong Kong
Corresponding author: Dr SY Cho (rony_cho@dh.gov.hk)
 
 Full paper in PDF
 
Abstract
Objectives: To identify the major causes and types of dental luxation and avulsion injuries, and their associated factors in primary school children in Hong Kong.
 
Design: Case series.
 
Setting: School dental clinic, New Territories, Hong Kong.
 
Patients: The dental records of children with a history of dental luxation and/or avulsion injury between November 2005 and October 2012 were reviewed. Objective clinical and radiographical findings at the time of injury and at follow-up examinations were recorded using a standardised form. Data analysis was carried out using the Chi squared test and multinomial logistic regression.
 
Results: A total of 220 children with 355 teeth of dental luxation or avulsion injury were recorded. Their age ranged from 6 to 14 years and the female-to-male ratio was 1:1.8. The peak occurrence was at the age of 9 years. Subluxation was the most common type of injury, followed by concussion. Maxillary central incisors were the most commonly affected teeth. The predominant cause was fall and most injuries occurred at school. Incisor relationship was registered in 199 cases: most of them were Class I. Comparison of the incisor relationship in study children and the general Chinese population in another study revealed a higher proportion of Class II and fewer Class III occlusions in the trauma group (P<0.0001).
 
Conclusion: Most dental luxation and avulsion injuries in Hong Kong primary school children are caused by fall. Boys are more commonly affected than girls, and a Class II incisor relationship is a significant risk factor.
 
 
New knowledge added by this study
  • This is the first epidemiological study of traumatic dental injury in children residing in Hong Kong. The present findings provide an important baseline for future comparison.
Implications for clinical practice or policy
  • As most injuries occur at school, it may be beneficial to educate primary school teachers about emergency care of children with dental trauma.
 
 
Introduction
Childhood injury is a major cause of death and disability in many countries, including Hong Kong.1 Although previous studies have reviewed general childhood injuries in Hong Kong children,1 2 dental injuries have not been specifically studied and reported. The oral region comprises 1% of the total body area, yet a population-based study in Sweden showed that it accounts for 5% of all body injuries at all ages.3 A recent study conducted by the Department of Health showed that injuries to orofacial areas accounted for 1.7% of all body injuries in children aged 14 years or below.1
 
Dental luxation and avulsion injuries account for 15% to 61% of all dental traumas to permanent teeth.4 It is an important public health concern as the treatment of such injuries is often complicated and requires specialist care.5 6 It also tends to occur at a young age during which growth and development take place and so long-term follow-up is needed.5 6 7 The average number of dental visits because of trauma to a permanent tooth during 1 year has been shown to be much higher than that required for a bodily injury.6 Information on how and where dental trauma occurs, and the associated risk factors are important data that can be used to plan a preventive strategy. There is, however, little information about the epidemiology of dental trauma in children residing in Hong Kong. The aims of this retrospective study were to identify the major causes and types of dental luxation and avulsion injuries, and their associated factors in primary school children attending a school dental clinic in Hong Kong.
 
Methods
This retrospective study was carried out at Fanling School Dental Clinic that provides care for approximately 30 000 primary school children in the Hong Kong New Territories East region. The study materials comprised dental records of patients with a history of dental luxation and/or avulsion injury between November 2005 and October 2012. All dental luxation and avulsion injuries were logged in the electronic records using specific codes: an electronic search of records was performed using the same dental condition codes (DC=concussion, DS=subluxation, DE=extrusion, DN=intrusion, DL=lateral luxation, and DA=avulsion). All cases were examined clinically by at least one of the three attending paediatric dentists at the clinic who were experienced in treating children with dental trauma. All records were reviewed by one single examiner, the paediatric dentist in-charge of the clinic. Information was recorded in Microsoft Excel and data analysis was carried out using the Chi squared test and multinomial logistic regression with PASW Statistics 18 software (SPSS Inc, Chicago [IL], US). The level of significance was set at P<0.05. To evaluate intra-examiner reliability, all selected records were reviewed by the same author 1 month after the original analysis and the findings of the two examinations compared for discrepancies.
 
Clinical examinations
Since November 2005, a standardised dental trauma form has been used in the clinic to facilitate follow-up care. The following parameters were recorded for patients who presented with dental luxation or avulsion injuries: date and time of injury, place where the injury occurred, cause of trauma, presence of other orofacial soft tissue injury, and the incisor relationship according to the British Standard Incisor Classification.8 The type of injury was classified according to the Andreasen modification of the World Health Organization classification,9 and included six types of injury to periodontal tissues (Table 1).
 

Table 1. Indices used in the present study
 
The adjacent apparently unaffected teeth on both sides were also included in the examination. For each tooth, objective clinical findings from the initial and follow-up examinations were recorded using the same standardised format and included the following: pulp sensitivity test; percussion tone; tenderness to percussion; tooth mobility; tooth colour; periodontal probing depths; and the presence of concomitant crown fractures and pulp exposure.
 
Radiographic examinations
An anterior occlusal radiograph together with periapical radiographs of the affected teeth were taken at the initial examination. At each follow-up appointment, periapical radiographs were repeated for the affected teeth. All periapical radiographs were taken using a standard film holder (Dentsply Rinn, Elgin [IL], US).
 
Follow-up examinations
All cases were followed up at regular intervals: 3 weeks, 6 to 8 weeks, 6 months, and then annually from the time of injury. Patients with dental avulsion were also seen on days 7 to 10 for splint removal and root canal treatment if indicated.
 
Results
A total of 220 children with 355 teeth of dental luxation or avulsion injury were recorded during the study period. Their ages ranged from 6 to 14 years (mean age, 9.2 years; standard deviation, 1.7 years). To assess whether age was an important factor, children were divided into two age-groups: 58% (n=128) were aged 6 to 9 years and 42% (n=92) were 10 to 14 years at the time of injury. The male-to-female ratio was 1.8:1, with 141 boys and 79 girls. The gender difference in prevalence was more prominent in children aged 9 years or above. The peak occurrence was seen at the age of 9 years (n=46), followed by the age of 8 years (n=44) and 10 years (n=38). Only one tooth was traumatised in 117 (53%) children. The predominant traumatic dental injury was subluxation, followed by concussion (Table 2). Over 65% of teeth with concussion or subluxation also had crown fractures. Maxillary central incisors (295 teeth) were the most commonly affected, followed by maxillary lateral incisors (38 teeth) and mandibular incisors (20 teeth). The cause of injury was recorded in 219 cases (Table 3). Fall (62%) was the predominant cause in both genders and age-groups, followed by collision (18%) and cycling (15%). There were no incidents of injury caused by motor vehicle accidents or fights. Statistical analysis using Chi squared test showed no significant difference in the cause of injury between genders (P=0.108) or between the two age-groups (P=0.193). The place where the injury occurred was recorded in 217 cases: most occurred at school (Table 4). Statistical analysis using Chi squared test showed a significant difference in the place of occurrence between genders (Chi squared=15.6, degrees of freedom=6, P<0.05), but no significant difference between the two age-groups (P=0.078). Multivariate analysis using multinomial logistic regression was then performed with gender and age-group as independent variables and place of injury as a dependent variable. Because of the relatively small number of cases, injuries that occurred in the playground, street, swimming pool, and other places were grouped into one category named as other places in the analysis. Injury occurring at school was then compared with injuries that occurred at home, on a cycling path, or in other places. School was chosen as the reference because (1) it was the most common place where injury occurred; and (2) univariate analysis of individual places of injury using the Fisher’s exact test showed no significant difference between genders regarding injuries at school whereas there were significant gender differences in injuries that occurred at home and on a cycling path (P<0.05). The results of the regression showed that boys were more commonly affected than girls (P<0.05; odds ratio [OR]=2.97; 95% confidence interval [CI], 1.05-8.43) for injuries that occurred on a cycling path in comparison with injuries at school. In the same model, younger children were significantly less commonly affected than older children (P<0.05; OR=0.42; 95% CI, 0.21-0.85) for injuries that occurred in other places compared with injuries at school.
 

Table 2. Types of dental luxation and avulsion injuries
 

Table 3. Causes of dental luxation and avulsion injuries in relation to age and gender
 

Table 4. Places where dental luxation and avulsion injuries occurred in relation to age and gender
 
Incisor relationship was registered in 199 cases: most were Class I (63%) [Table 5]. Since such information was not available for the whole study, it was decided to use data from a previous study of the general Chinese population of children as a retrospective comparison group.10 Comparison of these two studies showed that there was a higher proportion of Class II and fewer Class III occlusions in the trauma group than in the general Chinese population. Statistical analysis showed a significant difference between the two population groups (Chi squared=36.1, degrees of freedom=2, P<0.0001). Soft tissue injury occurred in the orofacial region in 87 children, and lips were involved in most instances (82%). Intra-examiner reliability was evaluated and complete concordance of all data and parameters was found between the two evaluations that were 1 month apart.
 

Table 5. The distribution of incisor relationship in this study compared with a previous study of the general Chinese children population10
 
Discussion
The difference in the proportion of causes of traumatic dental injury depends on various factors including culture, age-group, and population.11 12 In some developing countries, the most common cause of dental injury in children is violence.9 In this study, fall against a hard object such as the ground was the cause in over 60% of cases. This finding is in agreement with most other studies of traumatic dental injury in children.7 11 12 13 14 15 16 17 18 19 20 In a study of New Zealand children, fall was the most common cause in children aged 5 to 7 years, but collision became more common in the 8- to 10-year-old group.21 Nonetheless, such a trend was not observed in this study. Although dental injury due to cycling accidents was not uncommon in this study, this finding may be confounded by the fact that New Territories East has one of the busiest cycling path networks in Hong Kong.2 The use of helmets offers little protection to the lower face and jaw.9 It has been suggested that modification of the helmet design to cover the lower face may be beneficial. There were few sports-related injuries observed in this study. This may be because high-risk contact sports, such as rugby and ice hockey,5 are not very popular among Hong Kong primary school children. Compulsory use of mouth guards in those who participate in such activities may also be a contributing factor. There was no case of trauma due to a road traffic accident; this may reflect the legal requirement in Hong Kong for all passengers to wear a car seatbelt.
 
In this study more boys than girls had dental luxation and avulsion injuries in accordance with the findings of most other studies.7 13 14 15 16 17 18 19 22 23 24 One probable reason for the gender difference is that boys take more risks and participate more in sports activities. Nonetheless this gender difference has narrowed in recent studies, possibly due to an increased interest in sports among girls, especially in western societies.5 11 21 In this study, a greater gender discrepancy in frequency of dental injury was observed in the older age-group, in accordance with the findings of Kania et al’s study of elementary school children in the US.24
 
Previous studies of dental trauma in children have shown that most injuries occur between the age of 6 and 12 years.7 16 17 18 The present study population comprised primary school children attending a regional school dental clinic. The age of most primary school children in Hong Kong falls within the range of 6 to 12 years, and so most of the dental injuries for this group of children could be registered in this study. The peak occurrence of injury was seen in 9-year-olds, again in agreement with previous studies where the highest frequency of trauma to permanent dentition was observed in 9- to 10-year-olds.12 19 Nonetheless in studies from New Zealand21 and Iraq,14 the highest frequency of dental injury occurred in 5- to 7-year-olds. Glendor et al9 observed a marked increase in the incidence of dental injury in boys aged 8 to 10 years, with the incidence rather stable in girls. The same trend was also seen in this study. This may reflect the more vigorous play characteristics of boys in this age-group than girls.9
 
The majority of dental injuries involve the anterior teeth, especially the maxillary central incisors. The maxillary lateral and mandibular incisors are affected less frequently.5 9 Similar findings were also observed in the present study. The more prominent position of the maxillary central incisors makes them more vulnerable to injury. In addition, Kania et al24 opined that maxillary incisors are more prone to injury than their mandibular counterparts because of the mandible’s non-rigid connection to the cranial base. Most of the children in this study experienced trauma to only one tooth. This concurs with the findings from previous studies of dental injury in children.9 11 14 23 24 Noori and Al-Obaidi14 opined that when one tooth is traumatised, the majority of the force is dispersed and so no more teeth will be injured.14 It has been suggested that multiple tooth injuries are seen more often in more serious accidents such as motor vehicle accidents and violence.8 9 24 Concussion and subluxation together accounted for 85% of the cases in this study, in accordance with the findings of most previous studies on luxation and avulsion injuries in children.7 16 17 19 21 As the force and direction of impact determines the resultant type of injury, the findings from this study seem to suggest that most periodontal tissue injuries in Hong Kong primary school children are caused by more trivial incidents.9 Increased overjet and consequent incompetent lip closure is a significant risk factor to traumatic dental injury.7 9 13 14 15 22 23 24 In a study conducted in Iraq, 70% of children who had a dental injury had increased overjet.14 In many other studies, most children who sustained a dental injury had normal overjet, yet the percentage of children with increased overjet was significantly higher in children with dental trauma than in the general population.7 9 13 22 23 24 Similar findings were also observed in the present study. The more prominent tooth position and the lack of a cushioning effect from the upper lip in Class II malocclusion make the maxillary incisors more prone to injury.14
 
In many previous studies, the predominant place of injury occurrence in school-aged children was home, followed by school and other public places.9 13 21 22 In the present study, most injuries occurred at school. The second and third most common places of occurrence were home and cycling paths, respectively. This finding was in agreement with the population bodily injury survey of children aged 14 years or below in Hong Kong.1 One probable reason is that school children in Hong Kong have relatively more play-time at school than at home. In this study, 40% of children with a traumatic dental injury also suffered soft tissue injury in the orofacial region. This percentage was of similar magnitude to another study that involved a large proportion of children with dental luxation and avulsion injuries,17 but higher than a study with a high proportion of minor dental trauma such as simple fracture.12 This discrepancy may be because incidents that resulted in dental luxation or avulsion were usually more severe and could lead to more soft tissue damage.
 
One of the limitations of this study is its retrospective design. It is, however, extremely difficult to perform prospective trauma studies on a population basis.25 ‘Grab’ sampling was employed in this retrospective study, ie all patients treated in one clinic for dental luxation and/or avulsion injury were used in the sample. The conclusions from this study may therefore not be applicable to other parts of Hong Kong. To avoid inter-examiner error, all the records were reviewed by the most senior paediatric dentist in the clinic. The use of a standardised trauma form helps improve the accuracy of data collected during treatment.25 With the aid of a standardised form, the cause of dental injury was recorded in all but one case, and the place of trauma in all but three. This illustrates the importance of a standardised registry of dental traumatology.
 
This is the first epidemiological study of traumatic dental injury in children resident in Hong Kong and our data provide an important baseline for future comparison. Very often, school teachers are often the first to deal with an acute dental injury and it may be beneficial to educate them about the emergency care of children with dental trauma. For example, with avulsion injuries, where immediate management is critical for optimal healing, the teachers should be taught how to replant the tooth on site. If that could not be done, they should know how to store the avulsed tooth in an appropriate medium to prevent damage to the periodontal tissue. The effects of various factors on healing will be investigated and reported in a subsequent paper.
 
Dental traumas have social and economic impacts with regard to the treatment required but it is difficult to prevent dental injuries that are not sports-related.6 21 One option is to improve environmental factors to prevent falling at school and at home. Environmental and behavioural factors, however, were not included in this study so it is difficult to make conclusive suggestions in this regard. Further studies are warranted.
 
Conclusion
The causes and types of dental luxation and avulsion injuries in this group of Hong Kong children were similar to those of other studies, except that more injuries happened at school than at home. Most dental luxation and avulsion injuries in Hong Kong primary school children were caused by fall. Boys were more commonly affected than girls, and Class II incisor relationship was a significant risk factor. Motor vehicle accident or fight was not a common risk factor for dental injury in children. As most of the injuries occurred at school, it may be beneficial to educate primary school teachers about the emergency care of children with dental trauma.
 
Acknowledgement
The author thanks Dr Denise Fung for her statistical advice in this study.
 
References
1. Injury survey 2008. Hong Kong: Centre for Health Protection, Department of Health; 2010.
2. Chan CC, Cheng JC, Wong TW, et al. An international comparison of childhood injuries in Hong Kong. Inj Prev 2000;6:20-3. Crossref
3. Petersson EE, Andersson L, Sörensen S. Traumatic oral vs non-oral injuries. Swed Dent J 1997;21:55-68.
4. Andreasen FM, Andreasen JO. Luxation injuries of permanent teeth: general findings. In: Textbook and color atlas of traumatic injuries to the teeth. 4th ed. Oxford: Blackwell-Munksgaard; 2007; 372-403.
5. Glendor U. Epidemiology of traumatic dental injuries—a 12 year review of the literature. Dent Traumatol 2008;24:603-11. Crossref
6. Andersson L. Epidemiology of traumatic dental injuries. Pediatr Dent 2013;35:102-5. Crossref
7. Zhang Y, Zhu Y, Su W, Zhou Z, Jin Y, Wang X. A retrospective study of pediatric traumatic dental injuries in Xi’an, China. Dent Traumatol 2014;30:211-5. Crossref
8. British standard incisor classification. Glossary of Dental Terms BS 4492. London: British Standard Institute; 1983.
9. Glendor U, Marcenes W, Andreasen JO. Classification, epidemiology and etiology. In: Textbook and color atlas of traumatic injuries to the teeth. 4th ed. Oxford: Blackwell-Munksgaard; 2007: 217-54.
10. Lew KK, Foong WC, Loh E. Malocclusion prevalence in an ethnic Chinese population. Aust Dent J 1993;38:442-9. Crossref
11. Andreasen JO, Bakland LK, Matras RC, Andreasen FM. Traumatic intrusion of permanent teeth. Part 1. An epidemiological study of 216 intruded permanent teeth. Dent Traumatol 2006;22:83-9. Crossref
12. Eyuboglu O, Yilmaz Y, Zehir C, Sahin H. A 6-year investigation into types of dental trauma treated in a paediatric dentistry clinic in Eastern Anatolia region, Turkey. Dent Traumatol 2009;25:110-4. Crossref
13. Bendo CB, Paiva SM, Oliveira AC, et al. Prevalence and associated factors of traumatic dental injuries in Brazilian schoolchildren. J Public Health Dent 2010;70:313-8. Crossref
14. Noori AJ, Al-Obaidi WA. Traumatic dental injuries among primary school children in Sulaimani city, Iraq. Dent Traumatol 2009;25:442-6. Crossref
15. Taiwo OO, Jalo HP. Dental injuries in 12-year-old Nigerian students. Dent Traumatol 2011;27:230-4. Crossref
16. Sandalli N, Cildir S, Guler N. Clinical investigation of traumatic injuries in Yeditepe University, Turkey during the last 3 years. Dent Traumatol 2005;21:188-94. Crossref
17. Díaz JA, Bustos L, Brandt AC, Fernández BE. Dental injuries among children and adolescents aged 1-15 years attending to public hospital in Temuco, Chile. Dent Traumatol 2010;26:254-61. Crossref
18. Toprak ME, Tuna EB, Seymen F, Gençay K. Traumatic dental injuries in Turkish children, Istanbul. Dent Traumatol 2014;30:280-4. Crossref
19. Atabek D, Alaçam A, Aydintuğ I, Konakoğlu G. A retrospective study of traumatic dental injuries. Dent Traumatol 2014;30:154-61. Crossref
20. Hecova H, Tzigkounakis V, Merglova V, Netolicky J. A retrospective study of 889 injured permanent teeth. Dent Traumatol 2010;26:466-75. Crossref
21. Chan YM, Williams S, Davidson LE, Drummond BK. Orofacial and dental trauma of young children in Dunedin, New Zealand. Dent Traumatol 2011;27:199-202. Crossref
22. Glendor U. Aetiology and risk factors related to traumatic dental injuries—a review of the literature. Dent Traumatol 2009;25:19-31. Crossref
23. Zaragoza AA, Catalá M, Colmena ML, Valdemoro C. Dental trauma in schoolchildren six to twelve years of age. ASDC J Dent Child 1998;65:492-4,439.
24. Kania MJ, Keeling SD, McGorray SP, Wheeler TT, King GJ. Risk factors associated with incisor injury in elementary school children. Angle Orthod 1996;66:423-32.
25. Andersson L, Andreasen JO. Important considerations for designing and reporting epidemiologic and clinical studies in dental traumatology. Dent Traumatol 2011;27:269-74. Crossref

Efficacy and outcomes of transobturator tension-free vaginal tape with or without concomitant pelvic floor repair surgery for urinary stress incontinence: five-year follow-up

Hong Kong Med J 2015 Aug;21(4):333–8 | Epub 17 Jul 2015
DOI: 10.12809/hkmj144397
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Efficacy and outcomes of transobturator tension-free vaginal tape with or without concomitant pelvic floor repair surgery for urinary stress incontinence: five-year follow-up
Tracy SM Law, MB, ChB; Rachel YK Cheung, FHKCOG, FHKAM (Obstetrics and Gynaecology); Tony KH Chung, MD; Symphorosa SC Chan, FHKCOG, FHKAM (Obstetrics and Gynaecology)
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
 
This paper was presented at the 4th Annual Scientific Meeting of the Obstetrical and Gynaecological Society of Hong Kong (ASM OGSHK), 25 May 2014, Hong Kong
 
Corresponding author: Dr Tracy SM Law (tracylaw@cuhk.edu.hk)
 
 Full paper in PDF
 
Abstract
Objectives: To compare the 5-year subjective and objective outcomes of transobturator tension-free vaginal tape alone versus the same procedure with concomitant pelvic floor repair surgery for pelvic organ prolapse in women with urinary stress incontinence.
 
Design: Prospective cohort study.
 
Setting: Urogynaecology unit at a university hospital in Hong Kong.
 
Patients: Of 218 women, 96 (44%) received transobturator tension-free vaginal tape alone and 122 (56%) received transobturator tension-free vaginal tape with concomitant pelvic floor repair surgery from September 2004 to December 2009. The women were followed up annually for up to 5 years after the operation.
 
Main outcome measures: The 5-year subjective and objective cure rates were assessed. Subjective cure was defined as no urine loss during physical activity and objective cure was defined as no urine leakage on coughing during urodynamic study.
 
Results: Overall, 88 women receiving transobturator tension-free vaginal tape alone and 101 women receiving transobturator tension-free vaginal tape with concomitant pelvic floor repair surgery were followed up for 5 years after operation. The subjective and objective cure rates of the two groups were 70.5% versus 94.1% (P<0.01) and 80.3% versus 85.7% (P=0.58), respectively.
 
Conclusions: Transobturator tension-free vaginal tape is an effective treatment for urinary stress incontinence in women who received it alone or with concomitant pelvic floor repair surgery for pelvic organ prolapse, providing high subjective and objective efficacy for up to 5 years after operation. Transobturator tension-free vaginal tape with concomitant pelvic floor repair surgery achieved similar, if not better, long-term outcome compared with transobturator tension-free vaginal tape alone.
 
 
New knowledge added by this study
  • Transobturator tension-free vaginal tape (TO-TVT) is an effective treatment for urinary stress incontinence in women who received it alone or with concomitant pelvic floor repair surgery for pelvic organ prolapse (POP).
Implications for clinical practice or policy
  • TO-TVT can be performed along with pelvic floor repair surgery in women with POP, with a high cure rate.
 
 
Introduction
Urinary stress incontinence (USI) is a common distressing problem affecting women worldwide. The prevalence of USI ranges from 19% to 55% for different age-groups and communities with a prevalence of 33.8% in Hong Kong.1 2 3 4 It has a significant adverse impact on quality of life for 12% of women with the condition in Hong Kong.3 4 5 Surgical treatment with tension-free vaginal tape (TVT) is a known effective and durable procedure for patients in whom conservative treatment with pelvic floor exercises is unsuccessful.6 Retropubic TVT was first introduced in 1996 and long-term follow-up success rates of up to 77% have been reported 11 years after the procedure.6 However, TVT is associated with risk of bladder, urethra and vessel injuries, and voiding dysfunction.7 The development of transobturator TVT (TO-TVT) reduced the rate of complications with comparable efficacy to retropubic TVT in the short term.8 Such technique is now the first choice for the surgical treatment of USI.
 
Nearly 40% of women with pelvic organ prolapse (POP) have symptoms of USI and they often receive both continence surgery and pelvic floor repair (PFR) surgery at the same time. Yip and Pang9 compared women who underwent retropubic TVT with or without concomitant PFR surgery and concluded that TVT was equally effective with or without concomitant surgery for treatment of USI in women in Hong Kong. There is, however, little information on the efficacy of TO-TVT in this group of women.
 
The primary outcome of this study was to assess the objective and subjective cure rates at 1 and 5 years after operation in women with USI who received TO-TVT performed alone versus those who received TO-TVT with concomitant PFR surgery for POP. The secondary outcome was to compare any long-term complications of TO-TVT in both groups of women.
 
Methods
This was a prospective study involving all women with USI presenting to the out-patient clinic of a university hospital. All data were collected prospectively and input to a database established in 1996. There were 218 women with USI who received TO-TVT between 1 September 2004 and 31 December 2009. Ethics approval was obtained from the Institutional Review Board to conduct multifaceted analysis of this database (Clinical Research Ethics: CRE-2009.080).
 
Demographic information was obtained from all women with USI, followed by physical examination, including the standard POP quantification assessment, in the out-patient clinic. All women underwent standard urodynamic investigation, including uroflowmetry and filling and voiding cystometry following standards published by the International Continence Society10 with a Dantec Menuet (from 2004-2009; Dantec Medical A/S, Skovlunde, Denmark) or Maquet Radius (from 2009-2013; Maquet GmbH & Co. KG, Rastatt, Germany) multichannel urodynamic machine.
 
Women with USI who did not improve after pelvic floor exercise were offered TO-TVT.5 Women who had USI only underwent TO-TVT surgery, while women with both USI and POP received TO-TVT and concomitant PFR surgery. Vaginal hysterectomy and anterior or posterior colporrhaphy were performed accordingly as PFR surgery. Women with a history of predominant detrusor overactivity (DO), previous continence procedures, or transvaginal mesh repair for POP were excluded from the study. Women with mental incapacity were also excluded.
 
Women had either TOT (outside-in technique; Monarc Subfascial Hammock, American Medical Systems Inc., Minnetonka [MN], US) performed from September 2004 to June 2006 or TVT-O (inside-out technique; Gynecare TVT obturator system, Ethicon Inc [NJ], US) performed from July 2006 to December 2009 in the same urogynaecology centre. The change from TOT to TVT-O was because TVT-O was becoming available. In this study, 124 women underwent TOT and 94 women underwent TVT-O. Cheung et al11 reported TOT and TVT-O had high and similar subjective and objective efficacy (81%-84%). All procedures were performed or supervised by a urogynaecologist according to the original techniques.12 13 Cystoscopy was performed after the procedure to identify any bladder or urethral injury. The urinary catheter was removed the next day, voiding volume and pattern was reviewed, and post-voiding residual urine was measured. Women were discharged if residual urine was less than 100 mL.
 
Women were followed up 2 months after operation and then reviewed annually for 5 years. They were assessed subjectively by asking whether their USI symptoms became ‘better’, ‘same’, or ‘worse’. If there was no urine leakage when performing physical activities, the women were regarded as having ‘subjective cure’ of the USI. Those who responded ‘better’ but had persistent or recurrent USI symptoms were regarded as ‘subjective better’, irrespective of the frequency and amount of urinary leakage. Patients were asked whether they had voiding difficulty, urgency, groin or vaginal pain, or dyspareunia. Physical examination was conducted to check for POP and vaginal tape erosion. Urodynamic study was repeated at 1 and 5 years to assess the objective outcome. Severity of USI was classified according to the degree of urine leakage in the cough stress test: mild (following a series of coughs), moderate (with a few coughs), and marked (with a single cough). Objective cure was defined as no urine leakage upon coughing during urodynamic study. The cough stress test is a well-established test for USI with sensitivity of 98% and specificity of 100%.14 However, there was no standard set to categorise the severity of USI during urodynamic study. Thus, cough stress test was used to further categorise the severity of USI. Detrusor overactivity was defined as occurrence of involuntary detrusor contractions of >15 cm H2O during filling cystometry. Overactive bladder (OAB) was defined as urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection or other obvious pathology.10 Patients who did not return for follow-up were contacted and offered another appointment. If they defaulted again, they were interviewed over the telephone using the same set of questions to assess subjective outcome. Follow-up would be ceased if there was no significant problem after the 5-year follow-up.
 
Data were analysed using the Statistical Package for the Social Sciences (Windows version 17.0; SPSS Inc, Chicago [IL], US). Descriptive statistics of data were presented as mean ± standard deviation or number (%). Categorical variables were compared using Chi squared test or Fisher’s exact test. Continuous variables were compared using independent sample t test. A P value of <0.05 was considered statistically significant.
 
Results
Of 218 women who underwent TO-TVT between 1 September 2004 and 31 December 2009, 96 (44%) women had USI only and underwent TO-TVT alone, while 122 (56%) had USI and POP and underwent TO-TVT with concomitant PFR surgery. The PFR surgery was usually vaginal hysterectomy with anterior colporrhaphy. For preoperative data (Table 1), women who underwent TO-TVT and PFR surgery were older (mean, 65.6 vs 54.3 years; P<0.01), had higher parity (mean, 3.9 vs 2.6; P<0.01), and had more DO (11.5% vs 2.1%; P=0.02).
 

Table 1. Patients’ demographics
 
At 1 year after surgery, 197 (90.4%) women were reviewed at follow-up and 186 (85.3%) had urodynamic study. At 5 years, 189 (86.7%) women were either reviewed at follow-up or contacted by telephone (20 women) and 122 (56.0%) had urodynamic study. The mean follow-up times were similar: 59.3 ± 8.0 months for the TO-TVT group and 58.6 ± 8.0 months for the TO-TVT with concomitant PFR surgery group.
 
The subjective cure rate at 1 year was 78.0% for the TO-TVT group and 86.8% for the TO-TVT with concomitant PFR surgery group (Table 2); respective objective cure rate at 1 year was 80.7% and 87.4%. There was no statistical difference between the two groups. At 5 years, the subjective cure rate was 70.5% for the TO-TVT group and 94.1% for the TO-TVT with concomitant PFR surgery group. Women with TO-TVT with concomitant PFR surgery had statistically higher satisfaction. There was no difference in the objective outcome for the two groups at 5 years (80.3% vs 85.7%). After combining subjective cure and subjective better as one group for overall improvement of USI after surgery, the TO-TVT with concomitant PFR surgery group had significantly higher subjective improvement at 5 years (P=0.04). None required second operation for their USI during the 5-year follow-up.
 

Table 2. Subjective and objective outcomes at 1-year and 5-year follow-ups
 
In the study group, 10.2% and 20.6% had de-novo OAB at 1 and 5 years, respectively, and there was no statistical difference between the TO-TVT group and TO-TVT with concomitant PFR surgery group. More women developed de-novo DO at 5 years in the TO-TVT with concomitant PFR surgery group compared with TO-TVT group (14.3% vs 4.5%; P=0.12), although it did not reach statistical difference. Eight (8.3%) women in the TO-TVT group with de-novo OAB required medical treatment for their symptoms and five (4.1%) women in the TO-TVT with concomitant PFR surgery group required treatment (P=0.30).
 
No neurological complications resulting from the surgery were reported. Three women (two in the concomitant PFR surgery group and one in the TO-TVT alone group) had tape erosion requiring excision of the exposed tape (Table 3). The patients all presented with vaginal pain. The exposed tape was cut and the vaginal skin was repaired under local or regional anaesthesia. All three women had no recurrence of USI after tape excision at the 5-year follow-up. Two women (both from TO-TVT alone group) developed voiding difficulty with OAB symptoms and the tape was cut at 4 months and 18 months after the operation, respectively. Their voiding problem was resolved and both had no recurrence of USI after tape release. One woman (in the TO-TVT alone group) had groin pain 4 years after the operation and was treated conservatively with analgesics.
 

Table 3. Complications of transobturator tension-free vaginal tape 5 years after surgery
 
Discussion
Transobturator TVT has been proven to be safe and highly effective,11 15 and has become a standard treatment for USI. Pelvic floor repair surgery is commonly performed at the same time as continence surgery.16 However, there is limited information comparing the long-term efficacy of TO-TVT in women with or without concomitant PFR surgery. This study evaluated 5-year subjective and objective outcomes in the two treatment groups of women with USI alone and those having USI and POP who required treatment for both conditions.
 
Women in the TO-TVT with concomitant PFR surgery group were older, had had a higher number of vaginal births, and more were menopausal and had DO. This observation is likely due to the age of the women, as risk of DO also increases with age and more women had pre-existing DO in this group.
 
Subjective cure in our study was defined as feeling completely dry after TO-TVT operation. The 5-year subjective cure rate of the TO-TVT alone group was 70.5%. Although this appears to be lower than in the concomitant PFR surgery group of 94.1%, the result is comparable to most of the published data on long-term efficacy of TO-TVT. Angioli et al17 showed a 62% patient satisfaction rate and 73% objective success rate at 5 years. Abdel-Fattah et al18 also showed a 73% patient-reported success rate for TO-TVT at 3-year follow-up in 238 women.
 
We hypothesised that women with concomitant PFR surgery had a higher subjective cure rate because anterior colporrhaphy added an anti-incontinence effect. Furthermore, the main symptoms for this group of women might be related to POP so treating their POP could raise their overall satisfaction. Recurrence of POP may mask the symptoms of USI, but this hypothesis requires further analysis, as the recurrence rate of POP was not collected in this study. The above factors may account for the higher subjective cure rate observed, although the objective cure rates were high in both groups.
 
The 5-year overall subjective and objective cure rates were 83.1% and 82.8%, respectively, which are similar to international figures.19 20 Athanasiou et al19 reported 7-year overall subjective and objective cure rates of 83.5% and 81.5%, which included women who received TO-TVT alone or with concomitant PFR surgery, but there was no statistical comparison between the groups. Tsivian et al20 reported 82.9% versus 85.2% continence rates in patients undergoing TO-TVT alone versus those who received concomitant vaginal surgery at a mean follow-up period of up to 3 years. These studies, however, were either small or had short follow-up durations.
 
The long-term complication rate of TO-TVT is low. The most commonly encountered morbidity was de-novo DO after TO-TVT (9% at 5 years), which is similar to that reported in the literature.17 19 Athanasiou et al19 reported 7% de-novo urgency 7 years after TVT-O and Angioli et al17 found a 5-year de-novo urgency rate of 6.4%. The higher percentage of women developing de-novo DO at 5 years (9.0%) when compared with 1 year (5.4%) could be attributed to ageing. This difference also suggests that more women had de-novo DO in the prolapse group (14.3%) than in the TO-TVT alone group (4.5%) as the mean age of the prolapse group was higher. Our 5-year study also shows low rates of mesh erosion and voiding dysfunction after operation, and concomitant surgery does not impose higher complication rates.
 
We recommend TO-TVT with concomitant PFR surgery as the treatment of choice for women with symptomatic POP and USI. A recent meta-analysis showed a reduced risk of postoperative USI after combination surgery (mid-urethral sling with prolapse surgery) relative to prolapse surgery alone (5% vs 23%) for women with prolapse and symptomatic USI.21 In asymptomatic women with prolapse, however, only 7% required subsequent surgery for de-novo USI. Therefore, even with the promising result of combination surgery, it should only be performed in symptomatic incontinent women instead of as routine surgery for all women with prolapse because TO-TVT is not a risk-free procedure. Thus, preoperative evaluation of urinary symptoms and urodynamic study still plays a role in individual treatment planning.
 
There are limitations in this study. This was not a randomised controlled study and there was lack of blinding when assessing the objective outcomes. There were significant differences between the characteristics of the two groups (Table 1), and further randomised study is warranted to find out whether those factors contribute to the differences observed in subjective outcomes. We lacked a detailed questionnaire to evaluate the subjective cure rate and to assess quality-of-life aspect after the operation. The validated questionnaires in Chinese were only available after the study period.22 23 However, our previous study has confirmed the improvement in quality of life of women receiving continence surgery with or without PFR surgery.24 Although the response rate for subjective outcome measure was high at 5 years (overall response, 86.7%), fewer women (56.0%) returned for objective assessment using urodynamic study at 5 years.
 
Conclusions
Transobturator TVT is an effective treatment for USI in women who received it alone or with concomitant PFR surgery. This technique provides high subjective and objective efficacy for up to 5 years with a good safety profile. Transobturator TVT with concomitant PFR surgery achieved similar, if not better, long-term outcomes when compared with TO-TVT alone.
 
References
1. Zhu L, Lang J, Liu C, Han S, Huang J, Li X. The epidemiological study of women with urinary incontinence and risk factors for stress urinary incontinence in China. Menopause 2009;16:831-6. Crossref
2. Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 1998;46:473-80. Crossref
3. Pang MW, Leung HY, Chan LW, Yip SK. The impact of urinary incontinence on quality of life among women in Hong Kong. Hong Kong Med J 2005;11:158-63.
4. Cheung RY, Chan S, Yiu AK, Lee LL, Chung TK. Quality of life in women with urinary incontinence is impaired and comparable to women with chronic diseases. Hong Kong Med J 2012;18:214-20.
5. Fan HL, Chan SS, Law TS, Cheung RY, Chung TK. Pelvic floor muscle training improves quality of life of women with urinary incontinence: a prospective study. Aust N Z J Obstet Gynaecol 2013;53:298-304. Crossref
6. Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:1043-7. Crossref
7. Boustead GB. The tension-free vaginal tape for treating female stress urinary incontinence. BJU Int 2002;89:687-93. Crossref
8. Agur W, Riad M, Secco S, et al. Surgical treatment of recurrent stress urinary incontinence in women: a systematic review and meta-analysis of randomised controlled trials. Eur Urol 2013;64:323-36. Crossref
9. Yip SK, Pang MW. Tension-free vaginal tape sling procedure for the treatment of stress urinary incontinence in Hong Kong women with and without pelvic organ prolapse: 1-year outcome study. Hong Kong Med J 2006;12:15-20.
10. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29:4-20. Crossref
11. Cheung RY, Chan SS, Yiu KW, Chung TK. Inside-out versus outside-in transobturator tension-free vaginal tape: a 5-year prospective comparative study. Int J Urol 2014;21:74-80. Crossref
12. Jonsson Funk M, Levin PJ, Wu JM. Trends in the surgical management of stress urinary incontinence. Obstet Gynecol 2012;119:845-51. Crossref
13. Olsson I, Abrahamsson AK, Kroon UB. Long-term efficacy of the tension-free vaginal tape procedure for the treatment of urinary incontinence: a retrospective follow-up 11.5 years post-operatively. Int Urogynecol J 2010;21:679-83. Crossref
14. Swift SE, Yoon EA. Test-retest reliability of the cough stress test in the evaluation of urinary incontinence. Obstet Gynecol 1999;94:99-102. Crossref
15. Houwert RM, Renes-Zijl C, Vos MC, Vervest HA. TVT-O versus Monarc after a 2-4-year follow-up: a prospective comparative study. Int Urogynecol J 2009;20:1327-33. Crossref
16. Bai SW, Jeon MJ, Kim JY, Chung KA, Kim SK, Park KH. Relationship between stress urinary incontinence and pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2002;13:256-60; discussion 260. Crossref
17. Angioli R, Plotti F, Muzii L, Montera R, Panici PB, Zullo MA. Tension-free vaginal tape versus transobturator suburethral tape: five-year follow-up results of a prospective, randomised trial. Eur Urol 2010;58:671-7. Crossref
18. Abdel-Fattah M, Mostafa A, Familusi A, Ramsay I, N’dow J. Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3-year outcomes from the Evaluation of Transobturator Tapes study. Eur Urol 2012;62:843-51. Crossref
19. Athanasiou S, Grigoriadis T, Zacharakis D, Skampardonis N, Lourantou D, Antsaklis A. Seven years of objective and subjective outcomes of transobturator (TVT-O) vaginal tape: why do tapes fail? Int Urogynecol J 2014;25:219-25. Crossref
20. Tsivian A, Benjamin S, Tsivian M, et al. Transobturator tape procedure with and without concomitant vaginal surgery. J Urol 2009;182:1068-71. Crossref
21. van der Ploeg JM, van der Steen A, Oude Rengerink K, van der Vaart CH, Roovers JP. Prolapse surgery with or without stress incontinence surgery for pelvic organ prolapse: a systematic review and meta-analysis of randomised trials. BJOG 2014;121:537-47. Crossref
22. Chan SS, Cheung RY, Yiu AK, et al. Chinese validation of Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Int Urogynecol J 2011;22:1305-12. Crossref
23. Chan SS, Choy KW, Lee BP, et al. Chinese validation of Urogenital Distress Inventory and Incontinence Impact Questionnaire short form. Int Urogynecol J 2010;21:807-12. Crossref
24. Chan SS, Cheung RY, Lai BP, Lee LL, Choy KW, Chung TK. Responsiveness of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire in women undergoing treatment for pelvic floor disorders. Int Urogynecol J 2013;24:213-21. Crossref

Efficacy and safety of hylan G-F 20 injection in treatment of knee osteoarthritis in Chinese patients: results of a prospective, multicentre, longitudinal study

Hong Kong Med J 2015 Aug;21(4):327–32 | Epub 19 Jun 2015
DOI: 10.12809/hkmj144329
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE    CME
Efficacy and safety of hylan G-F 20 injection in treatment of knee osteoarthritis in Chinese patients: results of a prospective, multicentre, longitudinal study
CH Yan, FHKCOS, FHKAM (Orthopaedic Surgery)1; WL Chan, FHKCOS, FHKAM (Orthopaedic Surgery)2; WH Yuen, FHKCOS, FHKAM (Orthopaedic Surgery)3; Patrick SH Yung, FHKCOS, FHKAM (Orthopaedic Surgery)4; KY Ip, FHKCOS, FHKAM (Orthopaedic Surgery)5; Jason CH Fan, FHKCOS, FHKAM (Orthopaedic Surgery)6; KY Chiu, FHKCOS, FHKAM (Orthopaedic Surgery)1
1 Department of Orthopaedics and Traumatology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong
2 Department of Orthopaedics and Traumatology, Kwong Wah Hospital, Yaumatei, Hong Kong
3 Department of Orthopaedics and Traumatology, Queen Elizabeth Hospital, Jordan, Hong Kong
4 Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
5 Department of Orthopaedics and Traumatology, North District Hospital, Sheung Shui, Hong Kong
6 Department of Orthopaedics and Traumatology, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong
Corresponding author: Dr CH Yan (yanchunhoi@gmail.com)
 
 Full paper in PDF
 
Abstract
Objective: To study the efficacy and safety of single intra-articular injection of 6-mL hylan G-F 20 in Chinese patients with symptomatic knee osteoarthritis.
 
Design: Prospective case series.
 
Setting: Six government hospitals in Hong Kong.
 
Patients: Patients with primary knee osteoarthritis were recruited from six government hospitals from 1 October 2010 to 31 May 2012. All patients received 6-mL intra-articular injection of hylan G-F 20.
 
Main outcome measures: Pain visual analogue scale, functional visual analogue scale, and 5-point Likert scale on change of pain and function were assessed. Adverse events were checked. Radiographs were taken pre-injection and at 3 months and 1 year.
 
Results: A total of 110 knees of 95 patients with primary knee osteoarthritis were treated. The mean age of the patients was 62 (standard deviation, 9.8) years. All patients completed 1 year of follow-up. The mean pain visual analogue scale, functional visual analogue scale, and Likert value for pain and function showed statistically significant improvements at 6 weeks, 3 months, 6 months, and 1 year compared with the pre-injection values. No significant correlations were found between changes in visual analogue scale and age, body mass index, pre-injection radiological osteoarthritis severity, serum erythrocyte sedimentation rate, or C-reactive protein. Serial radiographs did not show any changes in the radiological severity of knee osteoarthritis. Overall, 16.4% of the patients experienced mild and self-limiting adverse events.
 
Conclusion: Hylan G-F 20 is a safe and effective therapy to relieve pain and improve function for up to 1 year in Chinese patients with knee osteoarthritis.
 
 
New knowledge added by this study
  • This study demonstrated that hylan G-F 20 is effective and safe to treat knee osteoarthritis in Chinese patients. Past studies were only conducted in Caucasian or mixed populations.
Implications for clinical practice or policy
  • Viscosupplementation could be a valid option for managing patients with chronic and symptomatic knee osteoarthritis. Single injection preparation is safe and effective. Injection can be performed in an out-patient setting.
 
 
Introduction
Osteoarthritis (OA) is a progressive degenerative joint disease initiated by multiple aetiological factors. When clinically evident, OA is characterised by joint pain, tenderness, stiffness, crepitus, effusion, and variable degrees of inflammation without systemic effects. Knee OA is a leading musculoskeletal cause of disability in elderly people around the world, and affects both Caucasian and Chinese populations.1 2 3 The burden of disease dramatically impacts health care costs. A local study found that, excluding joint replacement, the direct costs of managing OA ranged from HK$11 690 to $40 180 per person per year and indirect costs ranged from HK$3300 to $6640.4
 
There are many types of treatment for knee OA. These therapies can be divided into two major groups of non-surgical and surgical. Non-surgical therapies include exercise, weight loss, physical therapy, occupational therapy, medications (eg paracetamol, non-steroidal anti-inflammatory agents), and intra-articular injections (steroids, viscosupplementation). Surgical therapies mainly entail osteotomy and arthroplasty.5
 
Knee OA has been associated with a decrease in the elasticity and viscosity of the synovial fluid,6 7 8 which may alter the transmission of mechanical forces to the articular cartilage, possibly increasing its susceptibility to mechanical damage, or wear and tear. Viscosupplementation is an intra-articular therapeutic modality based on the physiological importance of hyaluronan in synovial joints. Its therapeutic goal is to restore the viscoelasticity of synovial hyaluronan, decrease pain, improve mobility, and restore the natural protective functions of hyaluronan in the joint.
 
Hylan G-F 20 is a cross-linked sodium hyaluronate with a high average molecular weight of 6 million daltons. Hylan G-F 20 is used in North America and Europe for the treatment of pain associated with knee OA. However, there are no data available in the literature on the clinical benefits of the viscosupplement in Chinese populations. Therefore, we carried out a prospective, multicentre, longitudinal study to investigate the efficacy and safety of hylan G-F 20 in the treatment of knee OA in local Chinese patients over a period of 1 year.
 
Methods
The study protocol was approved by the Institutional Review Boards/Ethics Committees of all six participating centres in Hong Kong. The inclusion criteria were: Chinese patients with primary knee OA who fulfilled the diagnostic criteria of the American College of Rheumatology; knee pain visual analogue scale (VAS) score of >50 (range, 0-100) and/or functional VAS score of >50 (0-100); and willingness to pay for the viscosupplementation and participate in the study. The exclusion criteria were: knee arthritis of other aetiologies; knee surgery or previous intra-articular injection in the knee within 1 year of the study; known allergy to chicken extracts; or unwillingness to pay for the viscosupplementation or participate in the study. Weight-bearing radiographs of the affected knee joint (standard anteroposterior and lateral views) were taken at the screening visit. Severity of knee OA in the tibiofemoral and patellofemoral compartments was classified according to the Kellgren-Lawrence (KL) system. The overall severity was defined as the highest KL grade in any of the compartments. We also documented the patients’ body mass index (BMI), and checked serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level.
 
Single intra-articular preparation of 6 mL of hylan G-F was injected into the patients’ knees in the out-patient clinic. Strict aseptic technique was adopted with skin disinfection and draping. The injection was administered through a direct lateral parapatellar approach. Knee joint aspiration was performed using a separate syringe before injection of the viscosupplement. After injection, the patients were allowed to resume normal activities, but were advised against vigorous exercise for 2 to 3 days. Ice therapy was recommended in case of transient increase in pain and swelling. Patients could continue with their routine analgesics on a pro re nata basis.
 
All patients were followed up regularly at 6 weeks, 3 months, 6 months, and 1 year. A telephone interview was conducted at 2 weeks to record any adverse events, if present. The severity of knee pain and knee function using 0-100 VAS scores (where 0 represents ‘no pain’ or ‘normal function’) were documented at each visit. Any changes in knee pain and functional limitations were charted using a 5-point Likert scale. Standard radiographs of the knee were repeated at 3 months and 1 year to detect any changes in radiological severity.
 
The change in pain and functional VAS scores before and after injection during each visit was compared using paired t test. Using correlation tests, we tried to find out the predictive factors (including age, sex, BMI, pre-injection KL grade, pre-injection pain VAS, ESR, and CRP) of favourable treatment response. All analyses were performed using the Statistical Package for the Social Sciences (Windows version 20.0; SPSS Inc, Chicago [IL], US). Statistical significance was assumed if the P value was <0.05.
 
Results
A total of 110 knees of 95 patients (31 men and 64 women) were recruited from six government hospitals in Hong Kong from 1 October 2010 to 31 May 2012. There were 59 left knees and 51 right knees. All patients completed 1 year of follow-up. The mean (± standard deviation) age of the patients was 62.0 ± 9.8 (range, 33-86) years. The mean BMI was 27.7 ± 4.6 kg/m2 (range, 18.3-46.8 kg/m2). The mean ESR was 23.35 ± 14.00 mm/h (range, 2.00-66.00 mm/h) and the mean CRP level was 1.3 ± 1.7 mg/L (range, 0.1-7.1 mg/L). The youngest patient in the study was 33 years old. His BMI was 25.9 kg/m2. X-rays of his right knee showed KL grade 1 OA in the patellofemoral compartment and KL grade 2 OA in the tibiofemoral compartment. He denied any previous injury to his knee.
 
The mean pain and functional VAS scores are shown in Figures 1 and 2, respectively. There were statistically significant improvements in pain and functional VAS scores after injection at every follow-up visit when compared with the pre-injection scores (paired t test, P<0.0001 for all). Significant differences were also found between the pain and functional VAS scores at 1 year and at 6 weeks (P<0.001 and P<0.01, respectively), 3 months (P<0.003 and P<0.01, respectively), and 6 months (P<0.01 for both). The score differences between 6 weeks, 3 months, and 6 months were not significant.
 

Figure 1. Changes in pain visual analogue scale (VAS) scores
The circles represent the means with the vertical lines 95% confidence intervals. There were significant decreases in VAS scores at 6 weeks, 3 months, 6 months, and 1 year compared with pre-injection level (all P<0.0001)
 

Figure 2. Changes in functional visual analogue scale (VAS) scores
The circles represent the means with the vertical lines 95% confidence intervals. There were significant decreases in VAS scores at 6 weeks, 3 months, 6 months, and 1 year compared with pre-injection level (all P<0.0001)
 
Likert values were coded as 1 to 5 with 3 being no change and 1 being much reduced. A sign test against a median of 3 and an alternate hypothesis that the sample median was less than 3 was used. Significant reductions in pain and functional limitations were found at 6 weeks (P<0.001 for both), 3 months (P<0.001 for both), 6 months (P<0.001 for both), and 1 year (P<0.03 for both). The proportion of patients feeling reduced or much reduced pain was 74% at 6 weeks, 75% at 3 months, 62% at 6 months, and 49% at 1 year. The proportion of patients feeling no change in pain level (when compared with pre-injection level) was 23% at 6 weeks, 22% at 3 months, 33% at 6 months, and 43% at 1 year.
 
Investigation of predictive factors of good clinical response did not demonstrate any significant correlation with age, BMI, pre-injection VAS, ESR, or CRP (Pearson’s tests). Sex (Welch’s t test) and pre-injection KL grade (analysis of variance test) did not significantly affect the treatment response.
 
Overall, 37 knees had KL grade IV OA, 38 had grade III OA, 30 had grade II OA, and five had grade I OA before injection. Radiographs showed no significant changes in KL OA grades at 3 months and 1 year. A total of 18 (16.4%) knees experienced adverse events, including pain (14 knees), swelling (2 knees), and warmth (2 knees). All of the adverse events were mild and self-limiting. No patients required hospital admission or extra clinic visits for these self-reported events.
 
Discussion
The evidence in the literature is still inconclusive regarding the clinical and biological efficacy of viscosupplementation. The 2006 Cochrane review summarised the results of 76 randomised controlled trials (RCTs) comparing hyaluronic acid (HA) and various other treatment modalities.9 The authors concluded that viscosupplementation is an effective treatment for knee OA with beneficial effects on pain, function, and global assessment, especially at the 5- to 13-week post-injection period. Although the sample size restriction may preclude any definitive comment on the safety of the products, no major safety issues were detected. The 2nd edition of the American Academy of Orthopaedic Surgeons guideline on treatment of knee OA claimed that “we cannot recommend using HA for patients with symptomatic knee OA”.10 This recommendation is based on the fact that although meta-analyses of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) for pain, function, and stiffness subscale scores all found statistically significant treatment effects, none of the improvements met the minimum clinically important improvement thresholds. The latest Osteoarthritis Research Society International guideline for nonsurgical management of knee OA claimed that the recommendation for intra-articular HA injection was ‘uncertain’, because the inconsistent conclusions among the meta-analyses and conflicting results regarding HA’s safety influenced the panel votes.11 One of the drawbacks of the meta-analyses and reviews is that they pooled the results of studies that investigated different viscosupplement formulations. These included low- and high-molecular-weight HA preparations of avian or bacterial origin. Hylan G-F 20 is a cross-linked HA derivative of avian origin, with relatively high molecular weight (average, 6000 kDa) and fluid rheological properties similar to those of knee synovial fluid of healthy young individuals. In a 26-week RCT, hylan G-F 20 single-injection formulation resulted in significant improvements in WOMAC pain score, observer-reported disease status, and patient-reported health status score.12
 
Our study is the first in Chinese patients to investigate the efficacy and safety of hylan G-F 20. The results show that the single 6-mL intra-articular injection could significantly improve pain and function in patients with primary knee OA. The beneficial effect could be sustained for up to 6 months. The VAS scores increased again by the 1-year follow-up visit, but the values were still significantly lower than the pre-injection levels. The 5-point Likert scale also revealed that about 75% of patients had reduced pain at 3 months, 62% at 6 months, and the percentage remained decreased at 50% at the 1-year follow-up visit.
 
A total of 16.4% of patients experienced mild and self-limiting local adverse reactions. No pseudoseptic reaction or severe acute inflammatory reaction was reported.13 The interview was conducted by telephone at 2 weeks after injection, and was partly carried out by research assistants or nurses. Some patients might have confused ‘additional/new pain over the injection site’ with ‘pre-existing OA pain’, which led to the higher self-reported adverse event incidence. There are reports on HA causing adverse reactions; the most common of which is an inflammatory reaction or flare at the injection site characterised by injection site pain and swelling.14 15 16 Hypersensitivity reactions to HA or avian proteins are listed as contra-indications for use of many of the HA products. Many of the inflammatory responses appear to be due to the molecular structure of the HA, as naturally derived hyaluronan sources appear to be better tolerated than highly cross-linked hyaluronan.13 17 18 Leopold et al19 demonstrated increased frequency of acute local reaction to hylan G-F 20 in patients receiving more than one course of treatment. Recently a murine model study showed a single injection of hylan G-F 20 led to less inflammation and lower antibody reaction when compared with a three-shot series of injections. In our study, the 6-mL single injection preparation was used. This approach offers another advantage over a multiple-injection regimen as it reduces the number of consultations, therefore saves money and manpower in government hospitals with limited health care resources.
 
The serial knee radiographs in our study did not show any changes (either progression or regression) of the radiological severity of OA after hylan G-F 20 injection. To date, there is no concrete evidence in the literature to support the disease-modifying effect of HA injection. The radiographic KL grading system may not be sensitive enough to detect minor changes in the articular cartilage. We also did not have a control group for comparison. In a magnetic resonance imaging–based RCT on articular cartilage volume change after four courses of hylan G-F 20 injection at 6-month intervals, the authors claimed that there was less cartilage loss in the treatment group at 24 months (2.7% over the medial tibial plateau and 2.6% over the lateral tibial plateau).20 Whether these differences are clinically significant is doubtful, however. We could not find any specific factors predicting good clinical response in our patients. This could be due to the relatively small sample size and the heterogeneity of our patients. The pre-injection parameters we investigated may not be sufficiently sensitive to survive the analysis.
 
There are a few limitations to this study. The pain and functional VAS scores were used because we believe they are patient-reported outcome measures, which would better reflect the clinical efficacy from the patients’ perspectives. The VAS scores are also easy to use, especially in the setting of a multicentre study. We did not include parameters such as knee range of motion, walking tolerance, or other knee scores as they were not the primary objectives of our study. It is well known that the placebo effect may account for 30% of the perceived benefits of medical treatment.21 We could not ascertain how much of the pain relief and functional improvement were attributable to the true therapeutic effects of hylan G-F 20 in view of the nature of our study design. A prospective, blinded, RCT may be able to eliminate the potential confounding factors and information bias. Changes in other treatment modalities during the follow-up period were not compared because of the potential complexity. It is difficult to standardise conservative treatment in terms of oral medication and exercise therapy, simply because patients with advanced knee OA may need stronger analgesics. Patients would also have a high non-compliance rate if we forced them to follow a single regimen. We decided to let all patients carry on with their usual conservative management and asked them if there were any changes in the pain and functional VAS scores during each follow-up after the viscosupplement injection.
 
Conclusion
This prospective, multicentre study showed that single intra-articular injection of 6-mL hylan G-F 20 was effective in providing statistically significant pain relief and functional improvement up to 1 year in Chinese patients with primary knee OA. Although adverse events were not uncommon, all of them were mild and self-limiting. Viscosupplementation with hylan G-F 20 could be a safe and beneficial option in managing patients with knee OA.
 
Declaration
The authors had not received any forms of financial or non-financial support from commercial companies. All patients purchased their own injection.
 
Acknowledgements
The authors would like to thank Drs Fu-yuen Ng (Queen Mary Hospital), Kan-yip Law (Prince of Wales Hospital), and Paul SC Yip (Queen Elizabeth Hospital) for their contribution of in-patient recruitment and data collection for the study.
 
References
1. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 1987;30:914-8. Crossref
2. Zhang Y, Xu L, Nevitt MC, et al. Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum 2001;44:2065-71. Crossref
3. Woo J, Leung J, Lau E. Prevalence and correlates of musculoskeletal pain in Chinese elderly and the impact on 4-year physical function and quality of life. Public Health 2009;123:549-56. Crossref
4. Woo J, Lau E, Lau CS, et al. Socioeconomic impact of osteoarthritis in Hong Kong: utilization of health and social services, and direct and indirect costs. Arthritis Rheum 2003;49:526-34. Crossref
5. Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM. A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin Arthritis Rheum 2013;43:701-12. Crossref
6. Mazzucco D, McKinley G, Scott RD, Spector M. Rheology of joint fluid in total knee arthroplasty patients. J Orthop Res 2002;20:1157-63. Crossref
7. Fam H, Bryant JT, Kontopoulou M. Rheological properties of synovial fluids. Biorheology 2007;44:59-74.
8. Schurz J, Ribitsch V. Rheology of synovial fluid. Biorheology 1987;24:385-99.
9. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005;(2):CD005321. Crossref
10. Jevsevar DS, Brown GA, Jones DL, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am 2013;95:1885-6.
11. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014;22:363-88. Crossref
12. Frampton JE. Hylan G-F 20 single-injection formulation. Drugs Aging 2010;27:77-85. Crossref
13. Goldberg VM, Coutts RD. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop Relat Res 2004;(419):130-7. Crossref
14. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Médicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579-85.
15. Hyalgan: prescribing information. Available from: http://products.sanofi.us/hyalgan/hyalgan.html. Accessed Jan 2009.
16. Synvisc: information for prescribers. Available from: http://synviscone.com/~/media/SynviscOneUS/Files/Synvisc-OnePI-70240104.pdf. Accessed Jan 2010.
17. Reichenbach S, Blank S, Rutjes AW, et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 2007;57:1410-8. Crossref
18. Jüni P, Reichenbach S, Trelle S, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 2007;56:3610-9. Crossref
19. Leopold SS, Warme WJ, Pettis PD, Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am 2002;84-A:1619-23.
20. Wang Y, Hall S, Hanna F, et al. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord 2011;12:195. Crossref
21. Shapiro A, Moris L. The placebo effect in medical and psychological therapies. In: Bergin A, Garfield S, editors. Handbook of psychotherapy and behavior change: an empirical analysis. 2nd ed. New York: Wiley; 1978.

Immigrants and tuberculosis in Hong Kong

Hong Kong Med J 2015 Aug;21(4):318–26 | Epub 17 Jul 2015
DOI: 10.12809/hkmj144492
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE    CME
Immigrants and tuberculosis in Hong Kong
CC Leung, MB, BS, FHKAM (Medicine); CK Chan, MB, BS, FHKAM (Medicine); KC Chang, MB, BS, FHKAM (Medicine); WS Law, MB, ChB, FHKAM (Medicine); SN Lee, MB, ChB, FHKAM (Medicine); LB Tai, MB, ChB, FHKAM (Medicine); Eric CC Leung, MB, BS, FHKAM (Medicine); CM Tam, MB, BS, FHKAM (Medicine)
Tuberculosis and Chest Service, Department of Health, Wanchai Chest Clinic, 1/F, 99 Kennedy Road, Wanchai, Hong Kong
Corresponding author: Dr CC Leung (cc_leung@dh.gov.hk)
 
 Full paper in PDF
 
Abstract
Objective: To examine the impact of immigrant populations on the epidemiology of tuberculosis in Hong Kong.
 
Design: Longitudinal cohort study.
 
Setting: Hong Kong.
 
Participants: Socio-demographic and disease characteristics of all tuberculosis notifications in 2006 were captured from the statutory tuberculosis registry and central tuberculosis reference laboratory. Using 2006 By-census population data, indirect sex- and age-standardised incidence ratios by place of birth were calculated. Treatment outcome at 12 months was ascertained from government tuberculosis programme record forms, and tuberculosis relapse was tracked through the notification registry and death registry up to 30 June 2013.
 
Results: Moderately higher sex- and age-standardised incidence ratios were observed among various immigrant groups: 1.06 (Mainland China), 2.02 (India, Pakistan, Bangladesh), 1.59 (Philippines, Thailand, Indonesia, Nepal), and 3.11 (Vietnam). Recent Mainland migrants had a lower sex- and age-standardised incidence ratio (0.51 vs 1.09) than those who immigrated 7 years ago or earlier. Age younger than 65 years, birth in the Mainland or the above Asian countries, and previous treatment were independently associated with resistance to isoniazid and/or rifampicin. Older age, birth in the above Asian countries, non-permanent residents, previous history of treatment, and resistance to isoniazid and/or rifampicin were independently associated with poor treatment outcome (other than cure/treatment completion) at 1 year. Birth outside Hong Kong was an independent predictor of relapse following successful completion of treatment (adjusted hazard ratio=1.76; 95% confidence interval, 1.07-2.89; P=0.025).
 
Conclusion: Immigrants carry with them a higher tuberculosis incidence and/or drug resistance rate from their place of origin. The higher drug resistance rate, poorer treatment outcome, and excess relapse risk raise concern over secondary transmission of drug-resistant tuberculosis within the local community.
 
 
New knowledge added by this study
  • Immigrants carry with them a higher tuberculosis incidence and/or drug resistance rate from their place of origin to Hong Kong.
Implications for clinical practice or policy
  • Their higher drug resistance rate, poorer treatment outcome, and excess relapse risk may increase the risk of secondary transmission of drug-resistant tuberculosis within the local community.
 
 
Introduction
Great disparity in tuberculosis (TB) rates has been reported in different parts of the world.1 Patients with TB from 22 high-burden areas accounted for over 80% of all notified TB cases in the world.1 Immigrants from these high-burden areas have often been blamed for their impact on the TB situation in many developed areas.2 3 4 5 6 7 8 9 10 11 12 A rapid increase in population was observed in Hong Kong in the last century, largely due to a heavy influx of immigrants from Mainland China.13 14 15 Despite remarkable socio-economic improvement over the past four decades, TB remains a common disease in Hong Kong. In 2006, the TB notification rate remained as high as 84.1/100 000.16 With continuing population movement between the Mainland and Hong Kong, there has been major concern about cross-border transmission of infections including TB.
 
A large-scale population census has been conducted in Hong Kong every 10 years since 1961, with a smaller by-census in-between. Tuberculosis is a statutorily notifiable disease, and basic demographic, clinical, and bacteriological data of notified cases are regularly captured by the TB notification registry. All residents are issued an identity card, and the identity card is used by both the TB notification registry and death registry as a unique personal identifier. Eighteen government chest clinics offer free programmatic case-finding and treatment services for TB patients under a centralised Tuberculosis and Chest Service of the Department of Health, with estimated programme coverage of over 80% of the population. Sputum culture and drug susceptibility testing are regularly performed by a centralised laboratory that is a Supranational Reference Laboratory within the World Health Organization/International Union Against Tuberculosis and Lung Diseases (WHO/IUATLD) network. Standard short-course regimens are used in line with the WHO recommendations. Patients are regularly followed up for 2 years after initiation of TB treatment to facilitate cohort analysis of treatment outcome. Using regularly captured data within the statutory registries and government TB programme, a longitudinal cohort study was performed to examine the impact of immigrant populations on the epidemiology of TB in Hong Kong.
 
Methods
Data on sex, age, place of birth, residency status, case category (new or retreatment), disease form (pulmonary with or without extrapulmonary involvement, or extrapulmonary only), sputum smear and culture results of consecutive patients notified within 2006 were obtained from the territory-wide TB notification registry of Hong Kong. An active case of TB was defined as positive isolation of Mycobacterium tuberculosis complex or, in the case of absent bacteriological confirmation, disease diagnosed on clinical, radiological, and/or histological grounds together with an appropriate response to anti-TB treatment. As part of the public health surveillance, bacteriological results of notified cases were verified with the reports from the central TB reference laboratory, with drug susceptibility test results for streptomycin, isoniazid, rifampicin, and ethambutol retrieved for culture-positive cases.
 
The sex- and age-stratified population data were obtained from the 2006 By-census for the following places of birth: Hong Kong (Group I); Mainland China (Group II); India, Pakistan, and Bangladesh (Indian subcontinent: Group III); Philippines, Thailand, Indonesia, and Nepal (other key Asian minority groups, Group IV); Vietnam (Group V); and other miscellaneous places of birth (Group VI).17 The crude incidence of TB among each of the above population groups was calculated with adjustment made by a multiplication factor (total notified cases / [total notified cases – cases with missing place of birth]) for cases with missing data on place of birth. The sex- and age-specific (by 5-year age-group) TB rates were derived from the overall population data and applied to the corresponding sex-age groups of each of the above six population groups to obtain the expected number of cases. The observed number of TB cases for each population group was compared with the respective number of expected cases to obtain the indirectly standardised TB incidence ratio. The 95% confidence intervals (CIs) were calculated by assuming a Poisson distribution in the occurrence of events. For those born in Mainland China, further stratification was made by the duration of residence in Hong Kong.
 
The treatment outcome 12 months after initiation of treatment was ascertained for those patients being managed by the government chest clinics under the Tuberculosis and Chest Service from the programme record form of the Tuberculosis and Chest Service. Treatment success was defined as cure or treatment completion (successfully completed treatment of ≥6 months for new cases and ≥8 months for retreatment cases), irrespective of subsequent relapse or death or loss to follow-up. All other treatment outcomes (including death before treatment completion, default, transferring out, still on treatment at 12 months after treatment initiation) were regarded as unsuccessful. Permanent residents who successfully completed treatment under the government TB programme were subsequently tracked up to 30 June 2013 through the territory-wide TB notification registry and death registry for relapse of TB or death.
 
Chi squared and Fisher’s exact tests were used as appropriate for categorical variables and analysis of variance was used for continuous variables. Logistic regression modelling was used for multivariate analysis of 12-month outcome. For censored data of TB relapse during follow-up, Kaplan-Meier analysis was used in univariate analysis and Cox proportional hazards modelling was used in multivariate analysis to adjust for potential confounders. A two-tailed P value of 0.05 was considered statistically significant.
 
The study was part of a public health surveillance exercise in tracking the profile and outcome of statutory TB notifications. It did not involve intervention on human subjects.
 
Results
A total of 6246 TB notifications were received in 2006, 480 of which were excluded because of duplicate notification or revised diagnosis, leaving 5766 cases in the 2006 TB notification registry. Of these, 18 cases involving tourists, 17 cases involving illegal immigrants, and 329 cases without information on place of birth were also excluded, leaving 5402 cases for analysis. Table 1 shows their basic characteristics as stratified by place of birth. The vast majority (92.3%) of TB cases involved residents born in either Hong Kong or Mainland China. Significant differences were observed between the six population groups in terms of sex and age distribution as well as proportions of new and pulmonary cases, but not proportions of either smear-positive or culture-confirmed cases.
 

Table 1. Basic characteristics of tuberculosis cases notified in 2006 in Hong Kong as stratified by place of birth
 
Table 2 summarises the incidence of TB and indirectly sex- and age-standardised incidence ratio (SIR) of TB for the six population groups. The TB SIR was significantly above 1 for those born in Mainland China (males and combined), Group III (females and combined), Group IV (females and combined), and Group V (males and combined), but significantly below 1 for those born in Hong Kong (males, females, and combined) and other miscellaneous places of birth (males, females, and combined). Mainland-born permanent residents (staying in Hong Kong for ≥7 years) maintained a higher TB risk than the population average for both sexes and combined. Nonetheless, recent Mainland immigrants with duration of stay of less than 7 years actually had a lower TB risk than the general population, despite sex and age standardisation.
 

Table 2. Annual incidences of active tuberculosis (all forms) in resident population by place of birth in 2006
 
Table 3 shows the resistance profile of 3474 (98.1%) culture-confirmed cases (with available drug susceptibility testing results) by place of birth. Table 4 summarises the results of univariate and multiple logistic analyses with respect to isoniazid, rifampicin, and multidrug resistance (resistance to both isoniazid and rifampicin) of 3434 culture-confirmed cases after combining all patients born in Asian countries listed under Groups III, IV and V, and excluding 40 patients with miscellaneous places of birth in Group VI that included very few drug-resistant cases. In the multiple logistic regression models using a backward stepwise elimination approach, only age <65 years, place of birth, and history of previous treatment (ie retreatment cases) remained important independent predictors of isoniazid, rifampicin, and multidrug resistance.
 

Table 3. Resistance to first-line drugs by place of birth
 

Table 4. Factors affecting isoniazid, rifampicin, and multidrug resistance at baseline
 
Of the 5402 subjects included in this study, 4319 (80.0%) were managed, at least at some stage of the disease, within the government TB programme. A total of 3304 (76.5%) patients successfully completed treatment within 12 months after initiation of treatment. Table 5 summarises the factors associated with 12-month treatment outcome in both univariate analysis and multivariate logistic regression analysis. Of those patients who successfully completed treatment, 3176 (96.1%) permanent residents in Hong Kong were followed up by cross-linking with the TB notification registry and death registry until relapse of TB, death or 30 June 2013, whichever was the earliest. After a mean (± standard deviation) duration of 5.28 ± 1.64 years of follow-up, 80 (2.5%) relapses were detected at a median (range) time interval of 1004 (225-2640) days after initiation of treatment, 37 (46.3%) of which were bacteriologically confirmed. In Kaplan-Meier analysis, the relapse risk was higher among permanent residents born outside Hong Kong than among those born in Hong Kong (3.0% vs 1.9%; log rank test, P=0.019). A consistently higher relapse risk was present among those born outside Hong Kong (adjusted hazard ratio=1.76; 95% CI, 1.07-2.89; P=0.025) after adjustment for gender, age, case category (new or retreatment), type of TB (pulmonary or extrapulmonary only), sputum smear, culture, and drug resistance to isoniazid and/or rifampicin at the baseline. The Figure shows the cumulative hazard curves by place of birth in and outside Hong Kong in Cox proportional hazards modelling.
 

Table 5. Treatment outcome of 4319 patients in government tuberculosis programme at 12 months after initiation of treatment
 

Figure. Cumulative hazard curves for relapse of tuberculosis after successful completion of treatment among 3176 permanent residents by place of birth
Cox proportional hazards modelling, adjusted for all variables shown in Table 5 (P=0.025)
 
Discussion
In this study, persons born in Hong Kong had a SIR of 0.90 (95% CI, 0.87-0.94), while those born in Mainland China (Group II), Indian subcontinent (Group III), Philippines, Indonesia, Thailand, Nepal (Group IV), and Vietnam (Group V) had significantly higher SIRs of 1.06, 2.02, 1.59, and 3.11 respectively (Table 2). Recent Mainland migrants (with length of stay <7 years), however, had a significantly lower SIR (0.51 vs 1.09) than other Mainland-born residents. Age <65 years, birth in Mainland or Groups III-V Asian countries, and history of previous treatment were independently associated with resistance to isoniazid and/or rifampicin (Table 4). Older age, birth in Groups III-V Asian countries, non-permanent residents, retreatment case, and resistance to isoniazid and/or rifampicin were independently associated with lower treatment success (cure/treatment completion) rate at 1 year (Table 5). Birth outside Hong Kong (Groups II-V combined) was an independent predictor of TB relapse among permanent residents after successful treatment completion under the government TB programme (Fig).
 
With the successful control of recent transmission of TB in Hong Kong, the majority of TB cases arose from endogenous reactivation of past infection.18 The higher SIR and drug resistance prevalence among Mainland immigrants and immigrants from Groups III-V Asia countries corroborate reports of higher TB incidence2 3 4 5 6 8 and drug resistance7 12 among immigrants in low-TB-burden countries. These higher risks among immigrants may have resulted at least in part from reactivation of latent TB infection9 10 11 acquired during their previous residence in, and/or travel to, their places of birth with higher burdens of TB and/or drug resistance.1 19 20 21 22 Apart from possible selection factors in migration, the progressive fall in TB prevalence in the Mainland over the recent decades22 could also have contributed to a lower burden of latent TB infection, and hence SIR, among recent Mainland immigrants compared with those who immigrated longer ago. Taking into consideration the independent effects of birth outside Hong Kong on both treatment outcome and relapse (Table 5 and Fig), population mobility may have adversely affected treatment adherence, and thus impacted on treatment outcome and/or relapse with possible acquisition of drug resistance. In line with these observations, a previous case-control study also identified younger age, non-permanent residents, and frequent travel as independent predictors of multidrug-resistant TB among previously treated patients in Hong Kong.23
 
Although this study showed an increased risk of TB among immigrants in Hong Kong, which is a metropolitan city with intermediate TB burden, the vast majority of TB cases still occurred among the majority population groups of local-born persons or permanent residents born in Mainland China (both of which were largely of Chinese ethnicity). This is contrary to the situation in most low-burden areas, where the majority of TB cases often came from foreign-born minority groups.2 3 12 The relatively high crude TB incidence rate of 55/100 000, even among the local-born (both genders combined) in this intermediate burden area (Table 2), could have reduced the risk differential between the immigrant groups and the local-born, thus reducing the influence of immigrants on the overall TB incidence. Nonetheless, the higher drug resistance rate, poorer treatment outcome, and higher relapse rate among immigrants in this study remain critical areas of concern. In a recent study on the transmission of drug-resistant TB in Hong Kong,24 46% of all multidrug-resistant TB cases were new cases with no previous history of treatment. This suggests ongoing transmission of these difficult-to-treat TB cases within our community. The degree of molecular clustering was as high as 65% among extensively drug-resistant TB cases, the majority of which did not have obvious epidemiological linkage, suggesting active transmission outside households or other conventional close contact settings.24
 
This study was based on territory-wide data from by-census, statutory registries, a centralised government TB programme, and centralised TB laboratory. The well-developed health care infrastructure in Hong Kong with easy access to free TB care services allowed capture of relevant information from TB patients notified in a by-census year and successful tracking of the majority of them for treatment outcome and relapse. Some degree of incomplete case ascertainment was still likely as in all other public health surveillance systems. Even though around 20% of the notified patients were managed outside the government TB programme, this might not have substantially confounded the internal comparisons among different population groups if access to care could be assumed to be roughly parallel. If the usual inverse care law25 did apply, the direction of bias would likely be underestimation of the risks among the immigrants as an underprivileged group. With the limited amount of socio-demographic and clinical information contained in the various statutory registries and programme forms, this study may not be in a strong position to analyse the complex mechanisms that underlie the observed associations between immigrants and treatment outcome or relapse. Further studies are therefore warranted to identify potential areas of intervention for specific minority groups.
 
Declaration
No external grant or support has been received for this study.
 
References
1. Global tuberculosis control report 2013. WHO/HTM/TB/2013.11. Available from: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf. Accessed May 2015.
2. Gilbert RL, Antoine D, French CE, Abubakar I, Watson JM, Jones JA. The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis 2009;13:645-51.
3. Das D, Baker M, Venugopal K, McAllister S. Why the tuberculosis incidence rate is not falling in New Zealand. N Z Med J 2006;119:U2248.
4. Cain KP, Haley CA, Armstrong LR, et al. Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med 2007;175:75-9. Crossref
5. Dye C, Lönnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009;87:683-91. Crossref
6. Svensson E, Millet J, Lindqvist A, et al. Impact of immigration on tuberculosis epidemiology in a low-incidence country. Clin Microbiol Infect 2011;17:881-7. Crossref
7. Baussano I, Mercadante S, Pareek M, Lalvani A, Bugiani M. High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991-2010, Italy. Emerg Infect Dis 2013;19:1437-45. Crossref
8. Manangan L, Elmore K, Lewis B, et al. Disparities in tuberculosis between Asian/Pacific Islanders and non-Hispanic Whites, United States, 1993-2006. Int J Tuberc Lung Dis 2009;13:1077-85.
9. Farah MG, Meyer HE, Selmer R, Heldal E, Bjune G. Long-term risk of tuberculosis among immigrants in Norway. Int J Epidemiol 2005;34:1005-11. Crossref
10. Patel S, Parsyan AE, Gunn J, et al. Risk of progression to active tuberculosis among foreign-born persons with latent tuberculosis. Chest 2007;131:1811-6. Crossref
11. McPherson ME, Kelly H, Patel MS, Leslie D. Persistent risk of tuberculosis in migrants a decade after arrival in Australia. Med J Aust 2008;188:528-31.
12. Long R, Langlois-Klassen D. Increase in multidrug-resistant tuberculosis (MDR-TB) in Alberta among foreign-born persons: implications for tuberculosis management. Can J Public Health 2013;104:e22-7.
13. Tuberculosis and Chest Service. Annual Report of Tuberculosis and Chest Service 1949. Hong Kong: Department of Health; 1950: 3.
14. Tuberculosis and Chest Service. Annual Report of Tuberculosis and Chest Service 1961. Hong Kong: Department of Health; 1962: 3.
15. Hong Kong Monthly Digest of Statistics April 2012, p.9. Available from: http://www.census2011.gov.hk/pdf/Feature_articles/Trends_Pop_DH.pdf. Accessed 3 Jul 2013.
16. Tuberculosis and Chest Service. Annual Report of Tuberculosis and Chest Service 2006. Hong Kong: Department of Health; 2008.
17. Census and Social Statistics Department of Hong Kong, 2006 Population By-census. Available from: http://www.bycensus2006.gov.hk/en/data/data2/index.htm. Accessed 3 Jul 2014.
18. Chan-Yeung M, Kam KM, Leung CC, et al. Population-based prospective molecular and conventional epidemiological study of tuberculosis in Hong Kong. Respirology 2006;11:442-8. Crossref
19. Zignol M, van Gemert W, Falzon D, et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 2012;90:111-119D. Crossref
20. Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012;366:2161-70. Crossref
21. Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis 2012;54:579-81. Crossref
22. Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet 2014;383:2057-64. Crossref
23. Law WS, Yew WW, Leung CC, et al. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2008;12:1065-70.
24. Leung EC, Leung CC, Kam KM, et al. Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city. Eur Respir J 2013;41:901-8. Crossref
25. Hart JT. The inverse care law. Lancet 1971;1:405-12. Crossref

Indications for and pregnancy outcomes of cervical cerclage: 11-year comparison of patients undergoing history-indicated, ultrasound-indicated, or rescue cerclage

Hong Kong Med J 2015 Aug;21(4):310–7 | Epub 17 Jul 2015
DOI: 10.12809/hkmj144393
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Indications for and pregnancy outcomes of cervical cerclage: 11-year comparison of patients undergoing history-indicated, ultrasound-indicated, or rescue cerclage
Lucia LK Chan, MB, BS, MRCOG1; TW Leung, PhD, FRCOG1; TK Lo, MB, BS, FHKAM (Obstetrics and Gynaecology)2; WL Lau, MB, BS, FRCOG1; WC Leung, MD, FRCOG1
1 Department of Obstetrics and Gynaecology, Kwong Wah Hospital, Yaumatei, Hong Kong
2 Department of Obstetrics and Gynaecology, Queen Mary Hospital, Pokfulam, Hong Kong
Corresponding author: Dr Lucia LK Chan (lucia118@gmail.com)
 
 Full paper in PDF
 
Abstract
Objectives: To review and compare pregnancy outcomes of patients undergoing history-indicated, ultrasound-indicated, or rescue cerclage.
 
Design: Case series with internal comparison.
 
Setting: A regional obstetric unit in Hong Kong.
 
Patients: Women undergoing cervical cerclage at Kwong Wah Hospital between 1 January 2001 and 31 December 2011.
 
Interventions: Cervical cerclage.
 
Main outcome measures: Pregnancy outcomes including miscarriage, gestational age at delivery, birth weight, and duration of pregnancy prolongation.
 
Results: Overall, 47 patients were included. Nine (19.1%) pregnancies resulted in miscarriage. The median gestational age at delivery was 35.7 weeks. Among the 23 patients who had history-indicated cerclage, only four (17.4%) had three or more previous second-trimester miscarriages or preterm deliveries. Among the 15 patients who had ultrasound-indicated cerclage, preoperative cervical length of ≤1.5 cm was associated with shorter prolongation of pregnancy, compared with that of >1.5 cm (median, 12.1 vs 18.4 weeks; P=0.009). Among the nine women who had rescue cerclage, those who underwent the procedure before 20 weeks of gestation delivered earlier than those underwent cerclage later (median, 22.5 vs 34.1 weeks; P=0.048).
 
Conclusions: Patients eligible for the Royal College of Obstetricians and Gynaecologists–recommended history-indicated cerclage remain few. The majority of patients may benefit from serial ultrasound monitoring of cervical length with or without ultrasound-indicated cerclage.
 
 
New knowledge added by this study
  • Women who had rescue cerclage before 20 weeks of gestation delivered significantly earlier than those who had the procedure performed later, supporting the expert opinion in the Royal College of Obstetricians and Gynaecologists (RCOG) guideline.
Implications for clinical practice or policy
  • The majority of patients may benefit from serial ultrasound monitoring of cervical length with or without ultrasound-indicated cerclage. A proposed algorithm on the management of patients, taking into consideration the RCOG guideline, is presented.
 
 
Introduction
Cervical cerclage was introduced by Shirodkar1 and McDonald2 in the 1950s, and has since become a common obstetric practice for the secondary prevention of preterm birth.3 4 Cervical cerclage is performed in patients with a history of cervical insufficiency; preterm labour or second-trimester miscarriage; cervical dilatation in the second trimester; or shortened cervix noted on transvaginal ultrasound examination.
 
Although cervical cerclage is a common obstetric procedure, there is still controversy regarding its efficacy and patient selection. While some studies showed that cervical cerclage did not prolong gestation or improve neonatal survival,5 6 7 8 9 others suggested that the procedure was beneficial.10 11 12 13 14 15 For instance, a large trial demonstrated that the incidence of preterm delivery before 33 weeks was halved by cervical cerclage among women with a history of three or more preterm deliveries before 37 weeks.10 It was shown in a meta-analysis11 and another study12 that among women with shortened cervical length with or without prior preterm birth, the risk of preterm birth with or without perinatal mortality was significantly reduced by cerclage. Rescue cerclage was also found to prolong pregnancy, reduce the risk of preterm labour,13 14 and improve neonatal survival and birth weight, even in women considered at low risk of preterm delivery in view of their obstetric history.15
 
Decisions for cervical cerclage are difficult and are often based on the clinical judgement of the senior obstetrician. The guideline on cervical cerclage published by the Royal College of Obstetricians and Gynaecologists (RCOG) in 2011, which classifies cervical cerclage into history-indicated, ultrasound-indicated and rescue cerclage, provides updated evidence in this area.16
 
Nevertheless, on review of the literature worldwide, no studies have been reported to investigate systematically the use and outcomes of cervical cerclage according to this new RCOG classification. Hence, this study aimed to review the indications and the pregnancy outcomes (miscarriage, gestational age at delivery, birth weight, prolongation of pregnancy, and rate of preterm birth before 34 weeks) of cervical cerclage in a regional obstetric unit in Hong Kong according to the RCOG categorisation. Any change in practice of cervical cerclage in the unit over 11 years was also reviewed.
 
Methods
This was a retrospective review of patients who had cervical cerclage performed in a regional obstetric unit in Hong Kong between 1 January 2001 and 31 December 2011. Ethics approval from the local institutional review board (Kowloon West Cluster Clinical Research Ethics Committee Reference: KW/EX-13-041[61-62]) was obtained. Patients who had undergone cervical cerclage were identified by the Clinical Data Analysis and Reporting System, which is a computerised database of the Hospital Authority, Hong Kong, using the key word “cervical cerclage”. The clinical data for these patients were retrieved and reviewed.
 
The patients were divided into three subgroups for data analysis. Group 1 included patients with history-indicated cerclage, that is, cerclage was performed in women with obstetric or gynaecological risk factors for spontaneous second-trimester loss or preterm delivery. Group 2 were patients with ultrasound-indicated cerclage, that is, cerclage was performed for women with cervical shortening (<2.5 cm) detected by transvaginal ultrasound examination, without exposure of fetal membranes in the vagina. This group comprised women who planned for history-indicated cerclage with preoperative sonographic finding of shortened cervix; had a history of preterm delivery before 37 weeks or second-trimester miscarriage(s) and underwent ultrasound monitoring of cervical length; or were incidentally found to have sonographic cervical shortening. Regular ultrasound examination was not performed for all patients and, if done, the frequency of monitoring was determined individually. Group 3 consisted of patients undergoing rescue cerclage, that is, cerclage was performed for women with premature cervical dilatation and exposure of fetal membranes in the vagina, which was either detected by ultrasound examination of the cervix or by speculum/physical examination for symptoms such as vaginal discharge, bleeding, or ‘sensation of pressure’, with or without a history of preterm birth before 37 weeks or second-trimester losses.
 
The definitions of history-indicated cerclage and ultrasound-indicated cerclage in this study were not exactly the same as the RCOG definitions,16 which suggest that history-indicated cerclage should be offered to women with three or more previous preterm births and/or second-trimester losses, while ultrasound-indicated cerclage should be offered to women with one or more previous preterm birth or second-trimester loss and sonographic cervical shortening (≤2.5 cm) before 24 weeks of gestation. To explore the significance of the differences in the category definitions, a sub-analysis was performed by dividing the present cohort into two groups. Group A included women who underwent history-indicated or ultrasound-indicated cerclage as defined by the RCOG guideline. Group B included women who had the procedure performed without strictly following the RCOG guideline.
 
All cervical cerclage procedures were performed by a senior obstetrician using the McDonald’s technique with Mersilene tape (Ethicon, West Somerville [NJ], US). Perioperative management—such as the use of prophylactic antibiotics and/or tocolytics, bed rest, and the choice of anaesthesia—was at the discretion of the operating team. The interval between the diagnosis of cervical incompetence and the performance of rescue cervical cerclage ranged from 0 to 3 days.
 
The Statistical Package for the Social Sciences (Windows version 20.0; SPSS Inc, Chicago [IL], US) was used for statistical analysis. The pregnancy outcomes studied included miscarriage, gestational age at delivery, birth weight, and duration of prolongation of pregnancy. Kruskal-Wallis test and Pearson Chi squared test were employed to analyse the relationship between indication for cerclage and various pregnancy outcomes. Patients who had history-indicated or ultrasound-indicated cerclage as defined by the RCOG guideline (group A) were compared with patients who had the procedure performed without strictly following the RCOG definition (group B) by the Mann-Whitney U test and Fisher’s exact test. Fisher’s exact test and Mann-Whitney U test were used, respectively, to compare the indications for cerclage and the various pregnancy outcomes between two different time periods (2001-2005 vs 2006-2011). A P value of less than 0.05 was taken as statistically significant.
 
Results
Overall, 47 patients with a singleton pregnancy were included in this study. The majority (87.2%) were Chinese. No immediate operative complications associated with cervical cerclage (namely membrane rupture or miscarriage within 1 week) occurred except for one miscarriage.
 
Among the 47 patients, nine (19.1%) pregnancies resulted in miscarriage, and 28 (59.6%) patients delivered after 34 weeks of gestation. The median gestational age at delivery was 35.7 (range, 14.9-40.1) weeks, with a median birth weight of 2270 (range, 75-3960) g. The median prolongation of pregnancy after cervical cerclage was 17.3 (range, 0.3-27.1) weeks. Among the 38 patients who delivered after 24 weeks of gestation, 29 (76.3%) delivered by normal spontaneous delivery, eight (21.1%) by lower segment caesarean section, and one (2.6%) by vacuum extraction.
 
Patients undergoing history-indicated cerclage (group 1; n=23)
Cerclage was performed at a median gestation of 14.6 (range, 12.4-19.6) weeks (Table 1). The median cervical length of the 20 patients who had it measured preoperatively by ultrasound examination was 3.5 (range, 2.5-4.8) cm. Four (17.4%) patients had three or more previous second-trimester miscarriages or preterm deliveries (ie the true history-indicated cerclage group as defined by the RCOG guidelines) and 13 (56.5%) had two or more second-trimester miscarriages or preterm deliveries. One patient did not have previous second-trimester miscarriage or preterm delivery, but had a history of large loop excision of transformation zone for cervical intraepithelial neoplasia, two terminations of pregnancy, and recurrent first-trimester miscarriages.
 

Table 1. Demographic characteristics and pregnancy outcomes of patients with different indications for cervical cerclage
 
No significant association was found between pregnancy outcomes and the gestation at which cerclage was performed. The pregnancy outcomes of the four women with three or more previous second-trimester miscarriages or preterm deliveries were compared with the other 19 women who had less than three second-trimester miscarriages or preterm deliveries. The former group tended to have a better pregnancy outcome, with higher gestational age at delivery (median, 38.1 weeks vs 37.4 weeks) and heavier birth weight (median, 3135 vs 2570 g) than the latter group, although these differences did not reach statistical significance.
 
Patients undergoing ultrasound-indicated cerclage (group 2; n=15)
Cerclage was performed at a median gestation of 18.6 (range, 14.3-23.4) weeks (Table 1). Shortened cervical length with or without funnelling of the cervix was detected on ultrasound examination. The median cervical length was 1.5 (range, 0-2.4) cm. All patients had cervical length of <2.5 cm.
 
Patients with a preoperative cervical length of ≤1.5 cm had significantly shorter prolongation of pregnancy compared with patients with a preoperative cervical length of >1.5 cm (median, 12.1 vs 18.4 weeks, P=0.009). Seven (46.7%) patients had cervical funnelling. No significant difference in pregnancy outcomes was detected between patients with and without cervical funnelling seen in the preoperative ultrasound examination. Among the 15 patients undergoing ultrasound-indicated cerclage, 13 (86.7%) had a history of second-trimester miscarriages or preterm deliveries. No significant difference in pregnancy outcomes was found between patients with or without a history of second-trimester miscarriages or preterm deliveries.
 
Patients undergoing rescue cerclage (group 3; n=9)
Rescue cerclage was performed at a median gestation of 19.3 (range, 16.1-23.0) weeks (Table 1). Cervical dilatation ranged from 2 to 3 cm at the time of diagnosis. Among the nine patients undergoing rescue cerclage, six (66.7%) had a history of second-trimester miscarriages or preterm deliveries. The diagnosis of cervical dilatation among these six women was made by either ultrasound assessment or physical examination based on symptoms. One patient had history-indicated cervical cerclage performed at a private hospital at 12 weeks of gestation. She presented with increased vaginal discharge at 22 weeks and was found to have cervical dilatation with a loosened cerclage stitch. Rescue cerclage was performed.
 
All the patients who miscarried after rescue cerclage had the procedure performed before 20 weeks of gestation. Women who underwent cerclage before 20 weeks delivered at an earlier gestation (median, 22.5 vs 34.1 weeks; P=0.048) and had smaller babies (median birth weight, 565 vs 2190 g; P=0.048) than women who had cerclage at a later gestation.
 
Comparison among the three groups of patients
There were no significant differences in age, body mass index, or parity between the three groups. Cerclage was performed at a significantly earlier gestation for patients with history-indicated cerclage compared with the other two groups (P<0.001; Table 1).
 
Regarding the pregnancy outcomes, it seems that patients undergoing rescue cerclage had a higher incidence of miscarriage than the other two groups (44.4% vs 20.0% in the ultrasound-indicated group and 8.7% in the history-indicated group), although the differences did not reach statistical significance (P=0.07), probably because of the small number of patients included in each group (Table 1).
 
Patients in the history-indicated and ultrasound-indicated cerclage groups had significantly longer prolongation of pregnancy, delivered at later gestation, and had heavier birth weight babies than women in the rescue cerclage group (Table 1). Nevertheless, there were no statistically significant differences in the gestational age at delivery or birth weight between patients in history-indicated cerclage group and the ultrasound-indicated group, although the former group had significantly longer prolongation of pregnancy than the latter group (P=0.002).
 
Comparison between patients in group A and group B according to the Royal College of Obstetricians and Gynaecologists definition
Comparison between patients who had history-indicated or ultrasound-indicated cerclage as defined by the RCOG guideline (group A) with patients who had the procedure performed without strictly following the RCOG definition (group B) was made. Group A consisted of four patients who had history-indicated cerclage and 13 patients who had ultrasound-indicated cerclage. Group B comprised 19 patients who had history-indicated cerclage and two patients who had ultrasound-indicated cerclage. No significant differences were detected in the demographic characteristics between the two groups. There were also no significant differences in the pregnancy outcomes between the two groups, including miscarriage rate, gestational age at delivery, preterm delivery rate before 34 weeks of gestation, birth weight, and prolongation of pregnancy (Table 2).
 

Table 2. Comparison between patients who had history-indicated or ultrasound-indicated cervical cerclage as defined by the RCOG guideline (group A) with patients who had the procedure performed without strictly following the RCOG definition (group B)
 
Comparison of the cerclage practice between 2001-2005 and 2006-2011
There was a trend for more ultrasound-indicated cerclage and rescue cerclage in 2006-2011 than in 2001-2005. More history-indicated or ultrasound-indicated cerclages were performed according to the RCOG’s recommendation in 2006-2011 than in 2001-2005 (50% vs 38.9%), although the difference did not reach statistical significance (P=0.532), probably because of the small sample size (Table 3).
 

Table 3. Comparison of perioperative management, mode of anaesthesia, and pregnancy outcomes for women undergoing cervical cerclage performed between 2001-2005 and 2006-2011
 
Pregnancy outcomes were similar between the two periods. However, there was less use of prophylactic tocolysis, but more frequent use of spinal anaesthesia and prophylactic antibiotics in 2006-2011 than in 2001-2005. The median duration of hospital stay was also significantly shorter in 2006-2011 than in 2001-2005 (Table 3).
 
Discussion
This retrospective study reviewed systematically the use and outcomes of cervical cerclage according to the new 2011 RCOG categorisation,16 although not all cases followed strictly the exact definition of history-indicated or ultrasound-indicated cerclage in the RCOG guideline. The data from the study may help provide more evidence on the application of the new guideline for making the decision for cervical cerclage among women at risk of or diagnosed with cervical incompetence.
 
In this study, only four (17.4%) patients fulfilled the RCOG recommendation16 for history-indicated cerclage (ie ≥3 previous second-trimester miscarriages or preterm deliveries), although more than half of the women in the group (n=13, 56.5%) had a history of two or more second-trimester miscarriages or preterm deliveries. This suggests that in clinical practice, women eligible for cerclage based on their obstetric history alone are few and, hence, serial ultrasound monitoring of cervical length is needed for most of the women at risk for cervical incompetence.
 
The optimal cervical length for recommending cerclage is controversial.12 17 One multicentre trial suggested that cerclage should be performed at cervical length of <1.5 cm,12 whereas a meta-analysis suggested that cerclage should be done for women with a singleton gestation with a previous preterm birth and cervical length of <2.5 cm.17 Our study showed that patients with preoperative cervical length of ≤1.5 cm had shorter prolongation of pregnancy compared with those with preoperative cervical length of 1.5 to 2.4 cm, supporting the recommendation that cervical cerclage should be offered if sonographic cervical shortening to ≤2.5 cm is detected (Fig). No significant difference in pregnancy outcomes was detected between patients with and without preoperative sonographic cervical funnelling. Review of the literature also suggests that cervical funnelling is not an independent risk factor for preterm birth.18 Hence, cervical funnelling is not recommended as a criterion to offer cerclage.
 

Figure. Algorithm for management of patients with potential cervical insufficiency
For patients with a history of ≥3 preterm births or second-trimester losses, cervical cerclage is offered. For those with only 1 or 2 prior preterm births or second-trimester losses, serial transvaginal ultrasound monitoring every 2 weeks is offered from 16 weeks until 24 weeks of gestation. Patients who are found to have a shortened cervical length of ≤2.5 cm will be offered cervical cerclage
 
Group A comprised patients who had three or more previous preterm deliveries or second-trimester miscarriages in the history-indicated cerclage group and patients with one or more previous preterm delivery or second-trimester miscarriage in the ultrasound-indicated cerclage group, and therefore was expected to carry a higher risk for preterm delivery or miscarriage and, hence, a worse pregnancy outcome compared with group B patients, who did not strictly fulfil the RCOG recommendation. Interestingly, no significant difference in pregnancy outcomes was detected between group A and group B patients. This may be due to the small sample size in each group. This, however, may mean that a less stringent criterion to offer cerclage other than the present RCOG recommendation may still be helpful for women at risk for cervical incompetence. A prospective study with a larger sample size to compare the pregnancy outcomes between these two groups of patients is warranted.
 
Women who had rescue cerclage before 20 weeks delivered significantly earlier than those who underwent the procedure later than 20 weeks. Although it is stated in the 2011 RCOG guideline that “in cases presenting before 20 weeks of gestation, insertion of a rescue cerclage is highly likely to result in a preterm delivery before 28 weeks of gestation”,16 this is based on expert opinion only, rather than data from previous studies. The result from this study provides new evidence to support such expert opinion.
 
Among patients with history-indicated or ultrasound-indicated cerclage, more patients fulfilled the RCOG’s recommendation in 2006-2011 than in 2001-2005 (50.0% vs 38.9%). This suggests that even before the publication of the RCOG guideline in 2011, the practice of cervical cerclage has already been changing, with a shift towards more stringent criteria for offering cerclage.
 
Strengths and limitations of this study
This study reviewed systematically the use and outcomes of cervical cerclage according to the categories in the new 2011 RCOG guideline.16 The data obtained may help in patient selection and counselling for cerclage. The major limitations include small sample size and lack of control groups. Moreover, not all patients included in the history-indicated and ultrasound-indicated groups fulfilled exactly the strict RCOG definitions for the respective groups.
 
The way forward
Although the RCOG guideline recommends history-indicated cerclage be performed in patients with a history of three or more previous second-trimester miscarriages or preterm deliveries, in clinical practice, this group of patients remains small. In the present study, only 17.4% of patients in the history-indicated cerclage group fulfilled such criteria. The majority of patients with potential cervical insufficiency encountered are those with a history of one or two previous second-trimester miscarriages or preterm deliveries, who may benefit from serial ultrasound monitoring of cervical length with or without ultrasound-indicated cerclage. Based on the findings from this study, an algorithm for the management of patients with potential cervical insufficiency is proposed (Fig).
 
A major limitation of ultrasound monitoring is the difficulty of timely identification of sudden cervical shortening and dilatation. The recommended frequency of ultrasound surveillance is not well established. Since this study demonstrated that rescue cerclage performed before 20 weeks of gestation was associated with a much poorer pregnancy outcome than procedures done at a later gestation, it is recommended that among patients with a history of one or two previous preterm births or second-trimester miscarriages, serial ultrasound monitoring should be performed every 2 weeks between 16 and 24 weeks of gestation (Fig). This may help optimise the early detection of cervical shortening in time and, hence, allow ultrasound-indicated cerclage be performed instead of rescue cerclage. Nevertheless, such practice requires a greater demand on manpower to perform ultrasound examinations and may not be applicable in small units with few staff. In order to improve the quality of care for patients with potential cervical insufficiency, allocation of resources for serial ultrasound monitoring for this group of patients is warranted.
 
Conclusions
Patients eligible for history-indicated cerclage according to the RCOG recommendation remain few. The majority of patients may benefit from serial ultrasound monitoring of cervical length with or without ultrasound-indicated cerclage, which is preferably performed at a cervical length between 1.5 and 2.5 cm.
 
Declaration
The authors have no conflicts of interest to declare.
 
References
1. Shirodkar VN. A new method of operative treatment for habitual abortion in the second trimester of pregnancy. Antiseptic 1955;52:299-300.
2. McDonald IA. Suture of the cervix for inevitable miscarriage. J Obstet Gynaecol Br Emp 1957;64:346-50. Crossref
3. Spong CY. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007;110:405-15. Crossref
4. Flood K, Malone FD. Prevention of preterm birth. Semin Fetal Neonatal Med 2012;17:58-63. CrossRef
5. Rush RW, Isaacs S, McPherson K, Jones L, Chalmers I, Grant A. A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery. Br J Obstet Gynaecol 1984;91:724-30. Crossref
6. Berghella V, Daly SF, Tolosa JE, et al. Prediction of preterm delivery with transvaginal ultrasonography of the cervix in patients with high-risk pregnancies: does cerclage prevent prematurity? Am J Obstet Gynecol 1999;181:809-15. Crossref
7. Rust OA, Atlas RO, Reed J, van Gaalen J, Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol 2001;185:1098-105. Crossref
8. Berghella V, Odibo AO, Tolosa JE. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol 2004;191:1311-7. Crossref
9. To MS, Alfirevic Z, Heath VC, et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004;363:1849-53. Crossref
10. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol 1993;100:516-23. Crossref
11. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005;106:181-9. Crossref
12. Owen J, Hankins G, Iams JD, et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009;201:375.e1-8. Crossref
13. Olatunbosun OA, al-Nuaim L. Turnell RW. Emergency cerclage compared with bed rest for advanced cervical dilatation in pregnancy. Int Surg 1995;80:170-4.
14. Althuisius SM, Dekker GA, Hummel P, van Geijn HP; Cervical incompetence prevention randomized cerclage trial. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2003;189:907-10. Crossref
15. Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. Management of cervical insufficiency and bulging fetal membranes. Obstet Gynecol 2006;107:221-6. Crossref
16. Cervical cerclage (Green-top Guideline No. 60), May 2011. London: Royal College of Obstetricians and Gynaecologists; 2011.
17. Berghella V, Keeler SM, To MS, Althuisius SM, Rust OA. Effectiveness of cerclage according to severity of cervical length shortening: a meta-analysis. Ultrasound Obstet Gynecol 2010;35:468-73. Crossref
18. To MS, Skentou C, Liao AW, Cacho A, Nicolaides KH. Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol 2001;18:200-3. Crossref

Pain management programme for Chinese patients: a 10-year outcome review

Hong Kong Med J 2015 Aug;21(4):304–9 | Epub 9 Apr 2015
DOI: 10.12809/hkmj144350
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Pain management programme for Chinese patients: a 10-year outcome review
MC Chu, FFPMANZCA1; Rainbow KY Law, MPhil2; Leo CT Cheung, MSc3; Marlene L Ma, MNurs4; Ewert YW Tse, MSc5; Tony CM Wong, PhD6; PP Chen, FFPMANZCA7
1 Department of Anaesthesia, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
2 Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong
3 Department of Physiotherapy, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong
4 Pain Management Centre, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong
5 Department of Occupational Therapy, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong
6 Department of Clinical Psychology, United Christian Hospital, Kwun Tong, Hong Kong
7 Department of Anaesthesiology and Operating Services, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong
Corresponding author: Dr MC Chu (chu0079@cuhk.edu.hk)
 
 Full paper in PDF
 
Abstract
Objectives: To review the clinical and social benefits of a pain management programme in Hong Kong.
 
Design: Prospective cohort study.
 
Setting: Tertiary out-patient clinic, Hong Kong.
 
Participants: Patients with chronic non-cancer pain and prolonged (mean, 46 months) psychosocial disability who joined the Comprehensive Outpatient Pain Engagement programme between 2002 and 2012.
 
Intervention: A structured 6-week out-patient pain rehabilitation course designed to improve function and reduce disability, regardless of the cause or severity of pain.
 
Main outcome measures: Social outcomes included return-to-work rate, hospital admissions, and out-patient visits. Physical outcomes included tolerance to sitting and standing. Psychological constructs such as mood, catastrophisation, self-efficacy, quality of life, and perceived performances were used. Each measure was taken before and 1 year after the programme.
 
Results: There was significant increase in return-to-work rate 1 year after commencement of the programme (35% after vs 17% before the programme; odds ratio=3.01), reduction in medical utilisation, and improvement in all physical and psychological measures. Pain intensity, psychological distress, and history of work-related injuries were not related to the likelihood of return to work. Shorter duration of pain and higher physical functioning score in 36-Item Short-Form Health Survey were prognostic indicators.
 
Conclusions: Patients with chronic pain who joined the Comprehensive Outpatient Pain Engagement programme showed significant functional improvement despite the long history of pain.
 
 
New knowledge added by this study
  •  A programme of pain management based on cognitive behavioural principles is an effective treatment with potentially significant social savings for sufferers of chronic non-cancer pain in Hong Kong.
Implications for clinical practice or policy
  •  The pain programme is an effective treatment, and shall be a significant part of chronic pain rehabilitative services in Hong Kong.
 
 
Introduction
Chronic pain is a common condition that affects about 10% of the population in Hong Kong.1 Patients with chronic pain suffer a variety of physical and psychological co-morbidities, become medically dependent, and have significant loss of quality of life and work capacity.2
 
Pain management programmes based on cognitive behavioural principles have been recognised as an effective treatment for various chronic pain conditions.3 Such programmes are structured to incorporate a variety of rehabilitative strategies, with clearly defined physical, psychological, and social outcomes. Such concepts and practices are, however, largely unknown to the Chinese community.
 
In 2002, the Comprehensive Outpatient Pain Engagement (COPE) programme was established at the Alice Ho Miu Ling Nethersole Hospital, Hong Kong, with reference to the model of the Active Day Patient (ADAPT) programme at the University of Sydney, Australia.4 This is a 14-day out-patient rehabilitation programme with 100 hours of clinical time per course. Core topics included education about pain pathophysiology, behavioural training with graded activities and exercises, pacing, relaxation, strengthening and stretching exercises, thought management, communication, as well as activity planning and appropriate use of medication. Individuals from multiple disciplines participated in the programme, including pain specialists, clinical psychologists, physiotherapists, occupational therapists, pain nurses, medical social workers, and hospital chaplains. To ensure consistency, all staff members were trained at the same Pain Management and Research Centre at the University of Sydney, and all courses were conducted according to a standardised timetable and protocol5 in use since its inception. From 2002 to 2012, 20 courses were conducted, with one to three courses per year, and eight to 12 participants per course.
 
An interim review in 20075 demonstrated improved physical, psychological, and social functioning among participants up to 1 year after the programme. The major limitation of that report was the small number of subjects (n=49). This report is an extended outcome study of the pain management programme. With more subjects, statistical significance should be improved.
 
Methods
All participants were recruited from the Pain Management Centre at the Alice Ho Miu Ling Nethersole Hospital, a tertiary referral centre in Hong Kong. They were patients with chronic non-cancer pain, irrespective of site and diagnosis.5 They were assessed by the clinical psychologist, pain nurse, and pain specialist for eligibility to join the programme as a possible pain management option. Those with untreated psychiatric conditions, significant suicidal or homicidal risk, illiterate (either written or spoken Cantonese), and non-acceptance to the therapy were not included in the study or the programme. Once recruited, prospective participants gave written informed consent for data collection and research, and agreement that medical treatment for pain control would remain unchanged until the programme commenced. On completion of the programme, routine follow-ups were arranged for up to 1 year.
 
A standardised set of measurements (Table 16 7 8 9 10) was used to assess the physical, psychological, and social functioning on the first day of the programme, and 12 months after each course. These measurements were self-reporting, self-administered questionnaires commonly used among pain clinics in Hong Kong and staff were familiar with the measurement tools. All measurements were made in Chinese and were validated in the local setting. Medical records of every participant were reviewed 1 year before and after the programme for history of injury, work status, pain-related admissions, or out-patient consultations.
 

Table 1. Statistics of outcome parameters6 7 8 9 10
 
Demographic and pain information were presented as descriptive statistics. Paired t test, Wilcoxon signed rank test, and contingency table with Fisher’s exact test were used to evaluate the overall effectiveness of the programme. Logistic regression predicting 12-month return-to-work status was performed with a history of injury at work, age, duration of pain, and the 36-Item Short-Form Health Survey (SF36) physical functioning as covariates using the ‘enter’ regression method. The Statistical Package for the Social Sciences (Windows version 10.0; SPSS Inc, Chicago [IL], US) was used for the calculations. A level of significance of P or Z<0.05 was accepted for the study.
 
This study was approved by the local ethics committee (Joint CUHK-NTEC Clinical Research Ethics Committee CREC2013.205).
 
Results
From 2002 to 2012, up to 4000 new cases of chronic pain were assessed at the clinic, and 158 patients were recruited. The exact number of patients for each of the exclusion criterion was unknown. Over the years, 14 participants withdrew during the course, and two defaulted from post-programme reviews. A total of 142 participants completed the course (Table 2).
 

Table 2. Demographics of participants who completed the pain programme (n=142)
 
There was a significant improvement in all of the physical and psychological parameters 1 year after the programme despite a long history (mean, 46 months) of signs and symptoms before the programme (Table 3). Despite similar pain-intensity ratings, functional tolerance (such as sitting and standing) had more than doubled. Depression, anxiety, and catastrophisation (psychological tendency to ruminate and magnify negative aspects of pain and health) scores were reduced. Self-efficacy, perceived performance and satisfaction with daily activities, and quality-of-life scores had improved. All changes were statistically significant (P<0.05).
 

Table 3. Physical and psychological outcomes
 
There was also a considerable improvement in work status (Table 4). Of the 142 participants, only 24 (17%) were working before the programme. The work statuses of 129 participants were known after the programme, of whom 49 (35%) were in work (including 28 who were not working before the programme). The odds ratio (OR) of participants working after the programme versus before was 3.01 (95% confidence interval, 1.71-5.30; P=0.0002). Further analysis of the 106 patients who were not working initially revealed that baseline pain intensity was similar among those who returned to work and those who did not (Table 5). There were also no statistically significant differences in the psychological and physical parameters except a higher SF36 physical functioning score (47.5 vs 39.0). Other significant differences included younger age (39.1 vs 44.0 years) and shorter duration of pain (28.3 vs 50.5 months) among those who returned to work. History of injury at work was also more common in this group (OR=3.36, Table 4). Logistic regression on these four significant variables predicting 12-month return-to-work status showed that duration of pain (OR=0.955, P=0.020) and SF36 physical functioning (OR=1.041, P=0.002) were significant independent predictors, while history of injury at work and age were not (Table 6).
 

Table 4. Work status at baseline and 12 months after the pain programme, and history of injury at work among the non-working participants before the programme, according to work status at 1 year after the programme
 

Table 5. Physical and psychological measurements of non-working participants before the programme, according to work status at 1 year after the programme (n=106)
 

Table 6. Logistic regression predicting return-to-work status for non-working participants before the programme (n=106)
 
Utilisation of medical resources was also significantly reduced after the programme: average out-patient attendance (visits per person per year) reduced from 7.95 to 6.39, and hospitalisation (admissions per person per year) reduced from 0.59 to 0.21. All changes were statistically significant (P<0.05).
 
Discussion
The COPE programme is one of the first pain programmes for psychosocial rehabilitation of patients with chronic non-cancer pain in a Chinese community. As the concepts of self-management, active coping, and functional improvement despite pain were new to the local patients and staff, it took a considerable effort to train staff and encourage local patients to join the programme. The slow recruitment prevented the authors from performing any randomised trial, and the sample size was statistically unrepresentative of the local chronic pain caseload (up to 400 new cases per year, recruitment rate of approximately 4%). Some important information, such as reasons for exclusion from the programme, were not included in the database. Selection bias might further limit the usefulness of the information.
 
Despite the limitations, the results demonstrated an all-round positive outcome for patients who completed the programme. The programme was not designed for pain reduction and indeed the pain intensity never changed, yet the participants became less fearful about pain and movement, and were able to continue to function despite the pain. The skills learnt in the programme were simple, self-managing, did not require special equipment or medications, and participants were encouraged to solve problem and adopt these skills in their own social setting. As the participants managed to see the dissociation between pain and disability, they become motivated to apply these skills continuously. This may have contributed to the lasting improvement.
 
The social improvement was very encouraging. Not only was there a lasting reduction in utilisation of medical resources, it came as a pleasant surprise that about one quarter of non-working participants were able to resume work. This is remarkable as this was a cohort with very long duration of pain, with most of the participants out of work for more than 2 years. It would also have been an unfavourable course of prolonged work absenteeism for patients with musculoskeletal pain and work-related injuries.11 12 13 Our post-hoc analysis reconfirmed that it remained a significant prognostic indicator of vocational outcome even after years of disability. As work was such an important outcome for the patient and the society, it would be useful to examine if early intervention could generate better return-to-work outcomes.
 
Another interesting finding was that most of the biological and psychological parameters were not associated with vocational outcome after the programme. In other words, while the psychological ‘yellow flags’ might be useful in chronic pain and disability prognosis,14 they might not be predictive of vocational outcome among this cohort of subjects. Apart from the long duration, our cohort of patients was characterised by very low quality-of-life scores in multiple domains. The poor psychological profile might have rendered most psychological measurements less discriminative than reported elsewhere.15 The only significant psychological prognostic indicator was a higher SF36 physical functioning score. This domain was known to have the strongest association with return-to-work among all the SF36 domains for subjects with chronic back pain,15 and stood out among other less discriminative domains for predicting outcome. Other prognostic factors, such as the patients’ expectation, social background, occupational ‘blue flags’ and the contextual ‘black flags’, might be in place and need further exploration.16 17 18 The economy might have also contributed to the favourable vocational outcome. However, the annual drop in unemployment (approximately 1%) during the period19 was much lower than the observed increase in work rate at 1 year (18%), and was probably a minor contribution to the overall improvement. The relationship between compensable injuries and return to work is much debated. Our data suggested that history of injury at work might have been an associating rather than independent variable in vocational outcome, with other confounding factors such as age or SF36. During each programme, the long-term goal setting would include a discussion on the impact of litigation and compensation on returning to work and may have reduced their potential detrimental effects.
 
Our findings provide a comparison with those from other non-cancer pain rehabilitation programmes in Hong Kong. In 2010, Luk et al20 published their rehabilitation programme outcome for patients with chronic low back pain. Following almost 400 hours of physiotherapy and occupational therapy, physical function improved although mood remained unchanged at 6 months.20 Approximately 52% of the participants returned to work 6 months after the programme.20 Those who returned to work showed a reduction in perceived disability, pain intensity, better physical performance, and similar mood compared with those who did not.20 The apparent discrepancy between Luk et al’s study20 and our study was due to differences in patient cohort and programme design. In Luk et al’s study,20 the average pain history was 22 months. These parameters compared favourably with our cohort of mean pain history of 46 months. Patients were referred from different sources (orthopaedics and pain clinics) with a different demographic (predominantly male in Luk et al’s group20 vs predominantly female in ours) and disease profile (exclusively back patients in Luk et al’s group20 vs heterogeneous in ours). The duration of therapy was almost 4 times longer in Luk’s study,20 allowing ample time for work strengthening and vocational training. On the contrary, our programme was designed for general rehabilitation and offered no vocational training. The comparison demonstrated the wide variety of presentation of pain patients, and the spectrum of therapies available in Hong Kong with different objectives and emphasis. Nonetheless both studies were in agreement that duration of absence from work was unanimously identified as a prognostic indicator for return to work.
 
In 2012, Tse et al21 published their outcome report of a pain management programme for chronic non-cancer pain among elderly home residents. Over 290 elderly subjects enrolled in the 8-week programme with physical exercises and multisensory art and craft therapy, together with pain education for their carer. The pain intensity in some areas (back and multiple joints) was significantly reduced after the programme, together with increased range of motion in all joints, and improvement in selected mood measurements. Perceived quality of life, as measured by SF12, did not differ significantly after the programme. There were no data on physical function, pain cognition, and social consequences. As the patient group and the programme design and outcome measurements were radically different to our study and that of Luk et al,20 results could not be compared nor conclusions drawn.
 
The practice of a multidisciplinary pain programme has also begun recently in Asia. In 2012, Cardosa et al22 reported a series of 120 patients who underwent the MENANG programme in Malaysia, a programme based on the same model (the ADAPT programme) as ours. Despite the differences in ethnicity, language and religion, the physical and psychological improvement was comparable to that of patients from Australia and Hong Kong. The efficacy was maintained despite the modifications made in both Asian programmes to adapt to the local culture and customs. The challenges of organising a pain programme were clearly felt by both Asian groups, as the small sample sizes suggest.
 
There are significant limitations to this study. The small sample size recruited from one single centre made it difficult to extrapolate the findings to another local chronic pain population. This was also an observational study although data were collected prospectively, and there was no control therapy group for comparison. The data set were primarily physical and psychological constructs, and some important social factors associated with return to work were not collected (such as the ‘blue flag’ factors) and included in the analyses, hence confounding was possible. There was also a lack of information about those who were excluded from the programme and why, thus significant selection (and self-selection) bias is present. Prospective randomised controlled trials are needed to confirm the effectiveness of the programme, or to compare the efficacy of different programmes with different designs.
 
Conclusions
The cognitive behavioural–based pain management programme improved quality of life and reduced disability for selected patients with chronic non-cancer pain in Hong Kong. More patients returned to work after the programme, and they consumed less medical resources, with potentially significant social savings. The strongest association with returning to work was a brief duration of pain rather than the baseline intensity of pain, compensable injuries, physical impairment, or psychological distress of the subject.
 
Acknowledgements
The authors would like to thank the multidisciplinary pain management team at the Alice Ho Miu Ling Nethersole Hospital, and the Pain Management and Research Centre at the University of Sydney for their assistance in the development of the COPE programme, data collection, and manuscript preparation.
 
References
1. Ng KF, Tsui SL, Chan WS. Prevalence of common chronic pain in Hong Kong adults. Clin J Pain 2002;18:275-81. Crossref
2. Blyth FM, March LM, Nicholas MK, Cousins MJ. Chronic pain, work performance and litigation. Pain 2003;103:41-7. Crossref
3. Chou R, Huffman LH; American Pain Society; American College of Physicians. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:492-504. Crossref
4. Nicholas M, Molloy A. Manage your pain: practical and positive ways of adapting to chronic pain. Australia: ABC Books; 2001.
5. Man AK, Chu MC, Chen PP, Ma M, Gin T. Clinical experience with a chronic pain management programme in Hong Kong Chinese patients. Hong Kong Med J 2007;13:372-8.
6. Leung CM, Wing YK, Kwong PK, Lo A, Shum K. Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr Scand 1999;100:456-61. Crossref
7. Yap JC, Lau J, Chen PP, et al. Validation of the Chinese Pain Catastrophizing Scale (HK-PCS) in patients with chronic pain. Pain Med 2008;9:186-95. Crossref
8. Lim HS, Chen PP, Wong TC, et al. Validation of the Chinese version of pain self-efficacy questionnaire. Anesth Analg 2007;104:18-23. Crossref
9. Carpenter L, Baker GA, Tyldesley B. The use of the Canadian occupational performance measure as an outcome of a pain management program. Can J Occup Ther 2001;68:16-22. Crossref
10. Lam CL, Gandek B, Ren XS, Chan MS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 1998;51:1139-47. Crossref
11. Frank JW, Brooker A, DeMaio SE, et al. Disability resulting from occupational low back pain: Part II: What do we know about secondary prevention? A review of the scientific evidence on prevention after disability begins. Spine (Phila Pa 1976) 1996;21:2918-29. Crossref
12. Lötters F, Burdorf A. Prognostic factors for duration of sickness absence due to musculoskeletal disorders. Clin J Pain 2006;22:212-21. Crossref
13. Cheng AS, Hung LK. Socio-demographic predictors of work disability after occupational injuries. Hong Kong J Occup Ther 2007;17:45-53. Crossref
14. Buck R, Barnes MC, Cohen D, Aylward M. Common health problems, yellow flags and functioning in a community setting. J Occup Rehabil 2010;20:235-46. Crossref
15. Gatchel RJ, Mayer T, Dersh J, Robinson R, Polatin P. The association of the SF-36 health status survey with 1-year socioeconomic outcomes in a chronically disabled spinal disorder population. Spine (Phila Pa 1976) 1999;24:2162-70. Crossref
16. Kuijer W, Groothoff JW, Brouwer S, Geertzen JH, Dijkstra PU. Prediction of sickness absence in patients with chronic low back pain: a systematic review. J Occup Rehabil 2006;16:439-67. Crossref
17. Iles RA, Davison M, Taylor NF. Psychosocial predictors of failure to return to work in non-chronic non-specific low back pain: a systematic review. Occup Environ Med 2008;65:507-17. Crossref
18. Buck R, Porteous C, Wynne-Jones G, Marsh K, Phillips CJ, Main CJ. Challenges to remaining at work with common health problems: what helps and what influence do organisational policies have? J Occup Rehabil 2011;21:501-12. Crossref
19. Hong Kong unemployment rate. Available from: http://www.tradingeconomics.com/hong-kong/unemploymentrate. Accessed 26 Sep 2014.
20. Luk KD, Wan TW, Wong YW, et al. A multidisciplinary rehabilitation programme for patients with chronic low back pain: a prospective study. J Ortho Surg (Hong Kong) 2010;18:131-8.
21. Tse MM, Vong SK, Ho SS. The effectiveness of an integrated pain management program for older persons and staff in nursing homes. Arch Gerontol Geriatr 2012;54:e203-12. Crossref
22. Cardosa M, Osman ZJ, Nicholas M, et al. Self-management of chronic pain in Malaysian patients: effectiveness trial with 1-year follow up. Transl Behav Med 2012;2:30-7. Crossref

Pages